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Research Experience for Undergraduates 
University of Arkansas 
 
 
 The University of Arkansas Department of Chemistry and Biochemistry hosted a 
National Science Foundation sponsored Research Experience for Undergraduates (REU) summer 
program for the 18th year.  The department first hosted an REU in 1959.  The 10-week summer 
program, funded by the National Science Foundation, allowed students an opportunity to gain 
hands-on experience in a chosen research area while introducing them to careers in scientific 
research in areas including analytical chemistry and sensor technology, biochemistry and protein 
dynamics, inorganic chemistry and nanotechnology, organic chemistry, and physical and 
theoretical chemistry. 
 
 Undergraduate chemistry majors, who were sophomores or juniors in fall 2006, applied 
to the program, which took place in the Ozark Mountain Plateau. 
 
 Outside the lab, students met each week to hear presentations from campus experts about 
topics ranging from how to get into graduate school and test-taking skills to ethics, and how to 
make a poster presentation.  A number of social activities took place throughout the summer to 
give students a chance to interact. 
 
 Selected students received a scholarship to pay for room and board and an allowance to 
attend a regional or national chemical conference in the 2006-2007 academic year.  Students 
involved in the program were enrolled as students at the U of A and received one hour of 
research credit.  The program was conducted from May 21, 2006 to July 27, 2006. 
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Tony Jude Award 
 
 Virginia native Zakiya Hoyett, a student at Norfolk State University, was the recipient of 
the Tony Jude Award for her research under the direction of Distinguished Professor Frank 
Millett.  She is featured next to her poster entitled “Production and Study of Amino Acid 
Mutations at the Cytochrome C Binding Site.” 
 
 The Tony Jude Award recognizes a student for outstanding research.  It is in memory of a 
former REU student who returned to the University of Arkansas and obtained a doctorate degree. 
 
 
 
 
 
Tony Jude Award Winner Zakiya Hoyett with REU co-director David Paul 
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REU 2006 Students 
 
                                  
 
Jamika Brown           Leethaniel Brumfield, III                                  Nick Gleason 
Norfolk State University                                         Langston University                                            University of Central Arkansas 
Mentor:  Neil Allison                                              Mentor:  Ingrid Fritsch                                        Mentor:  Denise Greathouse 
 
                                   
 
Cassandra Gomez-Potter                                     Christina Handford                                          Beth Hilburn 
Oklahoma Wesleyan University                             University of South Carolina-Upstate                Arkansas Tech University 
Mentor:  Dan Davis                                                 Mentor:  Xiaogang Peng                                    Mentor:  David Vicic 
 
                               
 
Zakiya Hoyett                                                       Kendra Jackson                                                  Carrie Peter 
Norfolk State University                                        John Brown University                                         John Brown University 
Mentor:  Frank Millett                                            Mentor:  Wesley Stites                                         Mentor:  Matthias McIntosh 
 
 
 
Carol Trana 
University of Arkansas at Monticello 
Mentor:  Robert Gawley 
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Faculty Project List 
 
 
Neil Allison Synthesis and Chemistry of Potential Organometallic 
Anticancer Drugs 
Donald R. Bobbitt Capillary Electrophoresis-based Micro-sequencing of Peptides 
and Proteins with “Ru(bpy)33+” Chemiluminescence 
Detection 
Dan Davis Protein-Protein Interactions in Photosynthesis:  Structure-
Function Relationships in Electron Transfer Proteins 
Bill Durham Electron-Transfer Reactions of Metalloproteins 
Ingrid Fritsch Microelectrochemical detection and microfluidics for lab-on-
a-chip applications:  protein, DNA, and microorganism 
analysis 
Denise Greathouse Solid phase synthesis and characterization of membrane-
active antimicrobial peptides 
Bob Gawley Synthetic and Mechanistic Organ(ometall)ic Chemistry; or 
Chemosensors for detection of Marine Toxins 
Jim Hinton Ultra High Magnetic Field NMR Study of Biological 
Channels 
Roger Koeppe Biophysical Studies of Single-Span Transmembrane Proteins 
and Membrane Channel Gating 
Matt McIntosh Total Synthesis of Biomedically Significant Complex Natural 
Products 
Frank Millett Biological Electron Transfer 
David Paul Development of Chemical Sensors for Clinical and 
Environmental Applications 
Xiaogang Peng Rational Synthesis and Manipulation of Colloidal 
Nanocrystals 
Peter Pulay Ab initio Calculation of the Vibrational and NMR Spectra of 
Protein Models 
Joshua Sakon Structure and function of drug-targets 
Lothar Schäfer  Molecular Dynamics Simulations of Adsorption Phenomena 
at the Clay Mineral/Aqueous solution Interface 
Wes Stites Exploring the influence of the denatured state upon protein 
stability, or Isolation, characterization, and impact upon blood 
clotting of human thrombomodulin in disease 
Z. Ryan Tian Syntheses and applications of ordered and complex one-
dimensional nanostructures 
David Vicic Synthesis, Structure and Reactivity of New Transition Metal 
Complexes 
Charles Wilkins Matrix-assisted Laser Desorption Fourier Transform Mass 
Spectrometry for Whole-Cell Bacteria and Polymer Analysis 
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Schedule of Events 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
UNIVERSITY OF ARKANSAS 
 NSF – CHEMISTRY – REU - SUMMER 2006 
Activities and Events 
Sunday, May 21 
1:00 p.m. – 4:00 p.m. Arrival, Check-In & Registration 
“Northwest Quad” Dormitory, Building “B” (front desk: (479)718-7802) 
http://housing.uark.edu/b-NWQ.htm  
Parking Registration 
 
3:00 p.m. – 5:00 p.m. Parking & Transit Available 
 
6:00 p.m. – 9:00 p.m. Welcome Dinner 
University House, Penguin Ed’s Barbeque 
 
Monday, May 22 
8:00 a.m. – 8:45 a.m. Breakfast 
    Quad Dinning Room (you must pay cash) 
 
9:00 a.m. – 10:00 a.m. Group Photo 
Front of Old Main 
 
10:00 a.m. – 12:00 p.m. Campus Logistics (Concurrent Sessions) 
 
RED  Session I:    10:00-10:50 a.m.    Session II:  11:00-11:50 a.m.   
YELLOW  Session II:   10:00-10:50 a.m.    Session I:   11:00-11:50 a.m.   
 
Session I:    Cash Checks and ID Cards Issued 
Arkansas Union  
 
Session II:   Library Orientation 
University of Arkansas Mullins Library 
 
12:00 p.m. - 1:30 p.m. Opening Luncheon 
    Place: Arkansas Union 
Speaker:  Dr. Gregory Weidemann, Dean 
Dale Bumpers College of Agricultural, Food & Life Sciences 
 
1:30 p.m. – 2:30 p.m. Campus Tour (Ending at Union) 
 
2:30 p.m. – 4:30 p.m. Departmental Logistics, 
Place:  Phoenix House 
Safety Briefing: Bill Durham, Department Chair 
    Meet your Mentor: Refreshments will be served 
    6 
    Purchase Parking Permits, Get Keys, Take Photos 
 
5:30 p.m. - ?   Pizza Party Dinner 
    Place:  Phoenix House 
Speaker:  Reggie House, Asst. Director for University                       
Housing 
 
Tuesday, May 23 Leadership/Team Building Activity (Includes Lunch) 
9:00 a.m. – 2:00 p.m. Graduate Education Building Auditorium 
Professor Ken Vickers 
Balance of day free for logistics.  Banking, Keys, etc. 
 
Wednesday, May 24 Go to Your Lab and Get Started! 
8:00 a.m.    
 
4:30 p.m. – 6:00 p.m. Dinner & Dialogue 
    Place: Reynolds Center, Seminar Room A 
Speaker:  Dr. Collis Geren, Dean of the Graduate School & 
Vice Provost for Research 
Topic: “It is just a Little Spider” 
 
Friday, May 26  REU Meeting 
1:00 p.m.   MAIN 523 
 
Saturday, May 27 – Monday May 29   Free for Memorial Day Weekend 
 
Wednesday, May 31 Dinner & Dialogue 
4:30 p.m. – 6:00 p.m. Place:  Reynolds Center, Seminar Room A 
    Speaker: Karla Clark 
Topic: Application to Graduate School 
     
Thursday, June 1   Evening Entertainment: 
6:00 p.m. – 9:00 p.m. Host:  Space and Planetary Science 
 
Friday, June 2  REU Meeting 
1:00 p.m.   MAIN 523 
    Speaker:  Dean Donald R. Bobbitt - Ethics 
 
Thursday, June 8  Evening Entertainment 
6:00 p.m. – 9:00 p.m. Host: Microelectronics-Photonics 
 
Friday, June 9  REU Meeting 
1:00 p.m.   MAIN 523 
    Speaker:  Dr. Xiaogang Peng 
    7 
 
Saturday, June 10  Practice GRE and GMAT test offered 
10 a.m.   AR Union, Rooms 507 & 511.  Testing is FREE  
    Participation requires pre-registration  
     
Monday, June 12  Canoe Trip 
 
 
Wednesday, June 14 Dinner & Dialogue 
4:30 p.m. – 6:00 p.m. Place: Reynolds Center, Seminar Room A 
    Speaker:  Dr. Robert Brady 
Topic:  Presentation Skills 
 
Thursday, June 15  Evening Entertainment 
6:00 p.m. – 9:00 p.m. Host: Chemistry 
 
Friday, June 16  REU Meeting 
1:00 p.m.   MAIN 523 
    Speaker:  Dr. Ingrid Fritsch 
     
Wednesday, June 21 
4:30 p.m. – 6:00 p.m. Dinner & Dialogue 
    Place: Reynolds Center, Seminar Room A 
Speaker:  Dr. Dennis Brewer, Associate Vice-Provost for 
Research 
    Topic:  Research and Ethics  
     
Thursday, June 22  Evening Entertainment 
6:00 p.m. – 9:00 p.m. Host:  Carver Project 
     
 
Friday, June 23  REU Meeting 
1:00 p.m.   MAIN 523 
Half-way Progress Reports Due, MAIN 523 
 
Thursday, June 29  Evening Entertainment 
6:00 p.m.-9:00 p.m. Host:  Physics 
 
Friday, June 30  REU Meeting 
1:00 p.m.   MAIN 523 
    Speaker:  Dr. Bob Gawley 
 
Saturday, July 1 – Tuesday July 4   Free for Independence Day Weekend 
 
Wednesday, July 5-6 Road Trip, National Lab 
1.5 Days    
    8 
Friday, July 7  REU Meeting  
1:00 p.m.   MAIN 523 
    Speaker:  Dr. Wesley Stites 
      
Wednesday, July 12 Final Carver Presentations 
3:00p.m. – 7:00 p.m.   
 
Friday, July 14  REU Meeting 
1:00 p.m.   How to Make a Poster 
    Jennifer Sims, Editor, Chemistry and Biochemistry  
 
Friday, July 21  REU Meeting 
1:00 p.m.   MAIN 523 
    Speaker:  TBA     
 
Thursday, July 27  Meeting in Miniature, Lunch Served 
10:00 a.m.      Phoenix House 
  
Friday,  July 28  End of Program 
5:00 p.m.    Final reports due.   
Dorm check-out. 
 
Saturday, July 29  End of Program 
a.m.     Get out of the Dorm, last check-out. 
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Investigation of Cyclyopropyl Carbene Formation from Bromo-silyl 
Cyclopropane 
Jamika Brown, Norfolk State University 
Norfolk, Virginia 
 
  
Introduction 
 
 A carbene is a neutral molecule that contains a carbon atom surrounded by only six 
valence electrons.1  The goal of this experiment is to form a cyclopropylcarbene that will 
rearrange to vinylallene and cyclopentadiene by conducting a reaction with bromosilyl 
cyclopropane and a fluoride ion as shown in Figure 1.  The fluoride ion will be used for a strong 
silicon-fluoride bond with concomitant cleavage of the carbon silicon bond.  After the carbon-
silicon bond cleavage, the carbene-carbene rearrangement will take place. This reaction, to our 
knowledge, has not been reported and will be a model reaction for a reaction that will produce a 
transition metal complexed vinylallene, that will be used in preparing quinone methides, a class 
of chemotherapeutic agents.2  Many researchers are further studying quinone methides to learn 
more about their substitution properties.  This research experiment was an attempt to form 
cyclopropyl carbene isomers more efficiently which will lead to a more efficient formation of 
quinone methides.   
 
 
TBS
BrBr
F
C
H2C
6
1
2
3  
Figure 1 The reaction of bromo-tert- butyldimethylsilyl-cyclopropane with a fluoride source that 
leads to the formation of the Cyclopropylcarbene isomers, vinylallene and cyclopentadiene. 
  
TBS
Br
Br
Br
1) n-BuLi
2) TBSCl
CHBr3
K-t-butoxide
4 5 6  
 
 
Figure 2 The bromo-TBS cyclopropane was generated by first addition of the dibromocarbene to 
butadiene and then by lithium-bromine exchange to give the bromo-TBS cyclopropane shown 
above. 
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Experimental Procedures 
 
 1,1-dibromo-2-vinylcyclopropane:  The procedure is a modification of the method that 
was used by Miller.3  A three neck 2 L round bottom flask was equipped with a nitrogen inlet 
was cooled to -15 to -10 ˚C in an external salt bath.  A stir bar, 150 ml of 1,3-butadiene, 750 ml 
of pentane, and 150 g (1.3 eq.) of potassium t-butoxide were added to the flask.  Bromoform 225 
g (0.89 moles) was added dropwise over a period of three hours and the mixture was allowed to 
stir overnight.  The solution was then allowed to slowly warm to 0 ˚C and stirred for thirty 
minutes.  The mixture was then allowed to slowly warm to room temperature.  500 ml of 
distilled water was added to the mixture and then stirred for twenty minutes.  The pentane 
solution was separated, washed with water (seven times with 250 ml) and saturated sodium 
chloride solution (one time with 250 ml), and dried over magnesium sulfate and concentrated on 
the rotary evaporator.  The crude dibromide was purified using distillation under the following 
conditions: 0.5 mmHg static vacuum and a 35 ˚C oil bath.  This reaction is shown in Scheme 1.  
The spectrum for the product is shown in Figure 3. 
  
Bromosilylcyclopropane: A Schlenk flask was flamed dried and placed under Nitrogen.  
The flask was then allowed to cool to -100 ˚C.  1.98 g (8.76 mmol) of dibromide and 30 ml of 
THF were added to the flask.  3.56 g of n-BuLi was added to the flask dropwise over a fifteen 
minute period.  The mixture then stirred for an additional thirty minutes.  1.32 g (8.76 mmol) of 
tert-butyldimethylsilyl chloride (in 4 ml of THF) was then added to the mixture dropwise over a 
period of fifteen minutes.  The reaction mixture was then allowed to stir for an additional thirty 
minutes.  The reaction mixture was allowed to slowly warm to 0 ˚C  and stirred for thirtyt 
minutes.  The reaction mixture was then allowed to attain room temperature.  The solution was 
then concentrated and purified using a silica gel column with hexanes as eleunt.  An NMR 
spectrum showed that the desired product had been obtained.  This reaction is shown in Scheme 
2.  The spectrum for the product is shown in Figure 4. 
 
Cyclopropyl Carbene: A Schlenk flask was flame dried and placed under nitrogen for 
each of the following reactions.  Using TBAF as the fluorine source: 650 ml of THF was added 
to the flask followed by 0.200 g (0.766 mmol) of the bromosilylcyclopropane.  The solution was 
then kept at -100 ˚C.  After the solution stirred five minutes, 42mg (0.16 mmol) of TBAF was 
added to the mixture.  The mixture was allowed to stir for one hour.  Since the reaction didn’t 
occur the reaction was performed two additional times with the modifications listed in Table 1.   
Using HF as the fluorine source: 0.400 g (1.5 mmol) of bromosilylcyclopropane was added to 
the flask followed by 0.122 g of 5% HF in an acetonitrile solution, (2 eq.).  The mixture was then 
allowed to stir at 55 ˚C overnight.  Since the reaction did not occur an additional 0.200 g of the 
5%HF/ CH3CN was added to the mixture and the temperature was increased to 100 ˚C. This 
reaction is shown in Scheme 3.  No observable products were obtained.  Using KF as the fluorine 
source: The following is a modification of the procedure used by Chan.7  0.300 g (1.1 mmol)of 
bromosilylcyclopropane was added to the flask followed by 10 ml of THF.  0.133 g of KF (2 
equiv.) and 0.133 (2equiv.) of 18-Crown-ether-6 was added to the flask.  The solution was 
allowed to stir at 40 ˚C for three days. No observable products were obtained.   
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Data Collection and Analysis 
 
 
Table 1: Reactions attempted during experimentation. 
 
Reactant(s) Temperature Reaction 
Time 
Product Number 
of Times 
Performed 
1,3-butadiene and 
pentane 
-15oC to -10oC 13 hours 
(overnight) 
1,1-dibromo-2-
vinylcyclopropane 
1 
1,1-dibromo-2-
vinylcyclopropane, n-
butyl lithium, and 
TBSCl 
-100 oC  2 hours bromosilylcyclopropane 8 
bromosilylcyclopropane, 
TBAF (42 mg), and 
THF 
-100 oC  2 hours No reaction 1 
bromosilylcyclopropane, 
TBAF (50mg), and THF 
-100 oC 6 hours No reaction 1 
bromosilylcyclopropane, 
TBAF (200mg), and 
THF 
-78 oC 6 hours Unknown  1 
bromosilylcyclopropane, 
5%HF/ CH3CN solution 
(2 equiv.), and THF 
-78 oC 3 hours No reaction 1 
bromosilylcyclopropane 
and 5%HF/ CH3CN 
solution (4 equiv.) 
Room 
temperature 
13 hours 
(overnight) 
No reaction 1 
bromosilylcyclopropane 
and 5%HF/ CH3CN 
solution (4 equiv.) 
95 oC 72 hours (3 
days) 
No reaction 1 
bromosilylcyclopropane, 
KF, 18-Crown-6-ether, 
and THF 
35 oC 72 hours (3 
days) 
No reaction 1 
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Results and Discussion 
 
 
Br Br
CHBr3
4 5  
Scheme 1. 
 
 
Br Br TBS
Br
1) nBuLi
2) TBSCl
   -100oC
5 6  
 
Scheme 2. 
 
Br TBS
HF/CH3CN
95oC
?
C
H2C
6 7  
 
 
Scheme 3. 
 
 
 The reactions that are presented in Scheme 1 and Scheme 2 were successful each of the 
times attempted.  However, contrary to published results4,5 the desiylation of  6 was 
unsuccessful.  Carbene-carbene rearrangement usually occurs at low temperatures6 to result in 
the product formation of 2. The ring opening desired for the formation of 3 requires a higher 
temperature that must also be taken into consideration.  Therefore reactions with a useful 
fluoride source may require elevated temperatures and possibly higher equivalents. 
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Conclusion 
 
 Three different fluoride sources were tested in this experiment to initiate carbon-silicon 
bond cleavage. The three fluoride sources were TBAF, HF, and KF.  Of the three only one, 
TBAF, reacted with the bromosilylcyclopropane resulting in data that could not be interpreted.  
None of sources cleaved the carbon-silicon bond.  This may be due to the temperature at which 
the reactions took place.  The ring opening that must occur to form the desired products may 
require higher temperatures for each reaction. 
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Figure 3  
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Figure 4 
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Solid State 31P and 2H NMR of Membrane Active Peptides in Bicelles 
Nicholas Gleason, University of Central Arkansas 
Conway, Arkansas 
 
 
Abstract 
 
Magnetically aligned bicelles can be used to study the structure of transmembrane 
proteins by NMR spectroscopy.  Bicelles consist of a combination of long-chain lipids and 
short-chain lipids that form a lipid bilayer membrane based on hydrophobicity [1].  The 
long-chain lipids form the planar portion of the bicelle while the short lipids align on the 
sides making the bicelle resemble the shape of a disk (Figure 1).  A current method for 
investigating the structure of membrane proteins by NMR is by forming oriented bilayers 
of peptides and lipids on glass plates.  The oriented sample technique takes a week or more 
to prepare compared to being able to complete bicelles in less than two days.  Bicelles were 
prepared with lipids alone and in the presence of peptides under a variety of conditions.  
Comparisons were made of 31P and 2H NMR spectra of membrane peptides prepared in 
oriented samples and in bicelles.   
 
  
Figure 1, Bicelle Structure, http://geimmxi.univ-rennes1.fr/ 
 
Introduction 
 
Samples prepared on glass plates can be placed in the NMR probe with the lipids aligned 
either parallel to (β = 0) or perpendicular (β = 90) to the magnetic field. In a magnetic field, 
bicelles spontaneously orientate with the long lipids aligned perpendicular to the magnetic field 
[1].  A signal at β = 90 therefore confirms that bicelles are present and well aligned in the 
magnetic field (Figure 2).  1,2-Di-O-Tetradecyl-sn-Glycero-3-Phosphocholine  (DMPC), an 
ether lipid containing two 14 carbon tails, was used for the long lipid.  1,2-Di-O-Hexyl-sn-
Glycero-3-Phosphocholine (DHPC), an ether lipid containing two 6 carbon tails, was used for 
the short lipid.  In some of the bicelle samples the ester lipid 1,2-Dimyristoyl-sn-Glycero-3-
[Phospho-rac-(1-glycerol)] (Sodium Salt) (DMPG) was also used as an additional 14 carbon 
lipid with a charge (Figure 3). 
  
      
 
 
 
Short-chain 
lipids 
Transmembrane 
peptide 
Long-chain 
lipids 
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Two Anthrax Toxin Receptor transmembrane peptides (ATR-TM) were synthesized by 
solid phase peptide synthesis methods using Fmoc-Alanine-d4 to label the peptides.   Due to the 
high costs of purchasing Fmoc-Ala-d4 it was prepared prior to peptide synthesis.  The native 
sequence (ATR-TM native, Syn # 672a) has three amphipathic Tryptophans (Trp) at the carboxy 
end that anchor it in the polar head groups of the lipid bilayer. An analogue with two more Trp 
residues at the amino end (ATR-TM Trp, Syn # 672b) was also synthesized. Bicelle samples 
were prepared with both ATR-TM peptides, with a model transmembrane peptide with both Trp 
and Lysine (Lys) anchoring residues at the carboxy and amino ends (KWALP 23; Syn # 651), 
and with a peripheral binding positively charged antimicrobial peptide (Ac-Lfb; Syn #637a) 
(Table 1).  Oriented bicelles were confirmed for KWALP 23 and Ac-LfB peptides, but not for 
the ATR-TM peptides. 
 Table 1, Peptide Sequences 
 
Peptide  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  
ATR-tm native Ac G G I L A I A1 L L I A2 F L L L A L A L L W W F W A Ea 
ATR-tm Trp Ac G W W L A I A1 L L I A2 F L L L A L A L L W W F W A Ea 
KWALP 23 Ac G K A L W L A2 L A3 L A1 L A L A L A L W L A K A Amide 
Ac-Lfb Ac R R Me-W Q W R   Amide 
Ac = acetyl; Ea = ethanolamine; 1. 70-75% deuterated, 2. 100% deuterated, 3. 50% deuterated 
Figure 3, lipids used for bicelles and oriented samples 
DMPC-ether (+/-) DMPC-ester (+/-) 
DHPC-ether (+/-) DHPC-ester (+/-) 
DMPG-ester (-) 
Ho 
Bilayer normal 
Figure 2, Bicelle alignment in magnetic field 
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Experimental Procedures 
 
Chemicals and Abbreviations 
 
 N-(9-Fluorenylmethoxycarbonyloxy)-succinimide (Fmoc-ONSu) was purchased from 
Sigma Aldrich.  Methanol was purchased from EMD.  Triethylamine (TEA) was obtained from 
Mallinckrodt OR.  Trifluoroacetic acid (TFA) was purchased from PE Biosystems.  Amino acids 
were purchased from either Nocabiochem or Advanced Chem Tech.  The WANG Ala resin, 
substitution 0.9 mmol/gram, was from Advanced Chem Tech.  N-Methylpyrrolidone (NMP), 
Methyl t-Butyl Ether (MtBE), dichloromethane (DCM), and acetonitrile were purchased from 
Burdick and Jackson. Hexafluoro-2-ethanol (HFIP) and 2,2,2-trifluoro-ethanol (TFE) were 
purchased from J.T. Baker. Dimyristolyphosphatidylcholine (DMPC) ether and ester, 
dihexylglycerophosphocholine (DHPC) ether and ester, and dimyristoylphosphatidylglycerol 
(DMPG) were obtained from Avanti Polar Lipids.  Dimethyl Sulfoxide (DMSO) and deuterated 
Alanine (Ala-d4) were purchased from Cambridge Isotope Laboratories, Inc.  1-
Hydroxybenzotriazol/ N, N-Dimethylformamide (HOBT/DMF), piperdine, and [2-(1 H-
benzotriazol-1-yl)-1,1,2,3-tetramethyluronium hexafluorophosphate] (HBTU) were bought from 
Applied Biosystems. 
 
Fmoc-Alanine-d4 Synthesis (Figure 4)   
                                        
In a 250 mL round bottom flask (RBF) 5 mmol of deuterated Alanine (Ala) was 
dissolved in five mL water. Five mmol of TEA was then added and mixed.  In a test tube 4.8 
mmol Fmoc-ONSu was dissolved in 5 mL acetonitrile by heating in a warm water bath.  After 
the Fmoc-ONSu was fully dissolved it was added to the deuterated Ala solution and left to stir 
for four hours.  The pH was checked every hour and TEA was added as necessary to maintain a 
pH between 8.5 and 9.0.  The solution was filtered with a Buchner funnel and filter paper and the 
precipitate was discarded.  The RBF was rinsed with methanol and the filtrate was returned to 
the RBF.   The filtrate was then concentrated on a RE 111 Rotavapor until it was reduced down 
to a yellowish film.  60 mL of 1.5 N HCl was added to the RBF and sonicated until all of the 
precipitate was off the sides of the RBF and in a single gobbet on the bottom.  With a Buchner 
funnel and filter paper the solution was filtered and rinsed several times with cold MtBE until the 
ether stopped turning yellow.  The precipitate was then allowed to dry in the vacuum line 
overnight on the filter paper. 
 To crystallize the product, the filtrate was returned to the RBF and 10 mL of ethyl acetate 
was dissolved while being heated in a water bath.  Five mL of hexane was added in one mL 
aliquots until it started to stay cloudy.  The contents of the RBF were transferred to a 
crystallization jar and it was then put in the freezer overnight.  There was only a small amount of 
crystals in the morning so the volume was reduced 1/3 under the nitrogen line and returned to the 
freezer overnight.  With a glass filter, the Fmoc-Ala-d4 was filtered.  The filtrate was returned to 
the crystallization jar and then to the freezer to try to obtain a second crop.  The glass filter with 
the Fmoc-Ala-d4 was dried overnight on the vacuum line and then collected.  The second crop 
stayed in the freezer for a week and then the crystals were filtered.  The total Fmoc-Ala-d4 crop 
was 535.0 mg, a 32% yield.  
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One mg of the 1st crop and 2nd crop of Fmoc-Ala-d4 were added to NMR tubes.  Both samples 
were dissolved in deuterated DMSO and analyzed by 1H NMR for confirmation of the product. 
                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From the spectrum (Figure 5) we see that the aromatic Fmoc group is attached and appearing 
around 8 ppm. We can also see by the absence of a CH3 peak around 1.0 ppm that the Ala is 
deuterated 
 
 
 
Figure 5, Fmoc addition to Ala-d4, 1st Crop 
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Solid Phase Peptide Synthesis of ATR-TM Native and ATR-TM Trp 
  
Solid phase peptide synthesis of ATR-TM Native and ATR-TM Trp were achieved using 
an ABI 433A peptide synthesizer with a UV monitor and beginning with a WANG Ala resin (0.9 
mmol/gram) for solid support. To synthesize the amino acids into a peptide the Fmoc protecting 
group on the first amino acid is removed with 20% piperdine / 80% NMP. The following amino 
acids were attached one at a time in a series of cycles after the previous alpha carboxyl group 
was activated with HBTU and HOBT. This process continues for the attachment of the rest of 
the amino acids. Peptides were synthesized in the C terminal to the N terminal direction.   The 
first 22 amino acids of both ATR-TM peptides were synthesized together.  After the process was 
completed the resin was removed from the synthesizer and dried on the vacuum line overnight.  
The sample was split into two samples and the first half was put back on the synthesizer to 
complete the sequence for the ATR-TM Native peptide.  The second half was then put back on 
the synthesizer to finish its sequence the ATR-TM Trp peptide.  After both peptide resins were 
completed, they were put back on the vacuum line to dry thoroughly. 
 
Peptide Cleavage 
 
 The peptide resins were transferred to scintillation vials and 2 mL distilled ethanolamine 
and 8 mL of DCM were added (20% ethanolamine in DCM).  The vials were flushed with 
nitrogen and then wrapped with foil.  The wrapped vials were put on an IKA KS 130 shaker for 
48 hours.  After shaking, the resin was filtered with a glass filter into a 250 mL RBF.  It was 
rinsed: 5 times with 1 mL DCM, 2 times with 1 mL HFIP, 5 times with 1 mL TFE, 5 times with 
1 mL DCM.  The resin was returned to the scintillation vial, and the liquid containing the peptide 
was put on the rotovaporator and reduced to 1/5 the original volume into a yellowish film.  The 
contents were transferred into two 50 mL centrifuge tubes and the RBF was rinsed with an 
additional 0.5 mL HFIP to transfer the rest.   40 mL of deionized water (dH2O) was added to 
each tube to precipitate the peptide.   The tubes were left to chill in the refrigerator overnight.  
After the solutions returned to room temperature they were centrifuged at 14,000 RPM’s for 2 
hours.  They were decanted and the tubes with the pellets were dried on the vacuum line 
overnight to finish the cleavage and obtain our peptide. 
 
Peptide Concentration Calculation 
 
 For each peptide 1 mL HFIP was added to dissolve the peptide in one of the centrifuge 
tubes containing peptide.  The peptide solution was poured into the other tube and then the first 
tube was rinsed with another 1 mL of HFIP to ensure all of the peptide in one tube.  It was 
sonicated for five minutes to make sure the peptide was in solution.  A 1:200 dilution was made 
by adding 5 μL of the peptide solution and 995 μL more HFIP in a cuvette.  The sample’s 
absorbance was measure using the Agilent 8453 diode array spectrometer using a 280 
wavelength.  With the absorbance we found the concentration of the original peptide solution 
using equation 1.   
 
 Equation 1:  Molar concentration =  
 
 
(Absorbance) * (Dilution Factor) 
(Pathlength)* ε * (# of Trp) 
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Figure 6: HPLC of A) ATR-TM Native, and B) ATR-TM Trp 
A 
B 
The absorbance of ATR-tm Native was found to be 0.778.    For the above equation: the 
dilution factor is 200, the pathlength is 1 cm, the peptide has 3 Trps, and the extinction 
coefficient, ε, is 5600 M-1cm-1.  The molar concentration of the ATR-tm Native solution was 
found to be .00926 M.  With the molecular weight of the peptide being 2861.6, the concentration 
of my solution is found to be 26.56 mg/mL.  The total yield from the cleavage of the ATR-tm 
Native peptide was therefore 25.56 mg/mL x 2 mL = 51.12 mgs. 
 
The absorbance of ATR-tm Trp was found to be 1.377.    For the above equation: the 
dilution factor is 200, the pathlength is 1 cm, the peptide has 5 Trps, and the extinction 
coefficient, ε, is 5600 M-1cm-1.  The molar concentration of the ATR-tm Trp solution was found 
to be .00984 M.  With the molecular weight of the peptide being 3063.38, the concentration of 
my solution is found to be 30.15 mg/mL. The total yield from the cleavage of the ATR-tm Trp 
peptide was therefore 30.15 mg/mL x 2 mL = 60.30 mgs. 
 
HPLC 
 Each peptide was analyzed with HPLC to make sure it was what was desired.  A 0.5 mL 
1 mg/mL sample was prepared from both peptide solutions.  The sample was inserted into the 
Hitachi L-7100 pump with a syringe using the gradient sequence from Table 2.  It was analyzed 
with a Hitachi L-2420 UV-Vis detector. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The single large peaks in the HPLC spectrum signify the purity of the peptide samples 
Minutes % A % B Gradient File 9: 
A = 99.9% Methanol + 0.1% TFA,  
B = 99.9% dH2O + 0.1% TFA   
 
0 96 4 
5 99 1 
10 99 1 
10.1 96 4 
14 96 4 
Table 2, HPLC Gradient 
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Mass Spectrometry 
 
 Mass spectrometry was also used to characterize the ATR-TM Native and Trp (Figure 7 
and Figure 8).  0.25 mL HFIP and 0.25 mL of the 1 mg/mL peptide solution was added to a 
small glass jar to make a 0.5 mg/mL peptide solution for MALDI-TOF mass spectrometer.   
Mass spectrometry was done at the University of Arkansas Statewide Mass Spectrometry 
Facility.  
 
 
 Figure 7, ATR-tm Native: Predicted Mass = 2855 + ~7D + Na+ = 2885 
 
 
 
 
 Figure 8, ATR-tm Trp: Predicted Mass = 3057 + ~7D + K+ = 3103 
 
Oriented Sample Preparation (Figure 9) 
 
On the bottom of two Petri dishes a total of 50 glass slides were placed in a radial 
position.  In a small conical bottom flask 80 µmoles of DMPC lipid and 4 µmoles of peptide 
were added.  The lipid and peptide mixture was dried under the nitrogen line to remove the 
chloroform solvent and then dried completely overnight under the vacuum line.  The lipids were 
redissolved in 400 µL methanol, 50 µL dH2O, and 400 µL chloroform.  With a glass syringe, 10 
µL of solution was applied to each of the 50 glass slides.  The slides were allowed to air dry and 
then were placed in the vacuum to dry completely for 48 hours.  The slides were then hydrated 
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by applying 2 µL of 100 mM NaCl in deuterium-depleted water to each slide with a glass 
syringe.  While the slides were still wet, they were stacked and placed them in a cuvette.  The 
cuvette was sealed with a glass cap and epoxy.  Epoxy was reapplied the next morning to ensure 
a good seal.  The oriented sample was then placed in the 45ºC heating block until the sample 
became transparent. 
The oriented samples are then analyzed using 31P NMR to check for a lipid bilayer 
alignment.   The samples are first put in the NMR probe with the slides parallel to the floor.  This 
orientation corresponds to β = 0.  If aligned we see a peak to the left of zero.  We then run the 
sample with the plates perpendicular to the floor called β= 90.  This produces a peak to the right 
of zero when the sample is in a bilayer. 
 
 
 
Figure 9, Preparation of NMR oriented samples 
 
Bicelle Preparation  
 
 For preparation of the bicelle sample, the stock lipids in chloroform were first taken out 
of the freezer and allowed to come to room temperature.  The proportion of long lipids to short 
lipids is known as the q value and it has been shown that a q value of 3.2 is favorable to have 
good uniaxial alignment [1].  The lipids were added to a 15 mL pear-shaped glass flask.  The 
peptides were either dissolved in 100 µL solvent and then added to the lipid solution or added 
directly as a dry resin to the lipid solution.  The peptide was added in a 1:20 peptide: lipid ratio 
to the bicelles.  The lipid-peptide mixture was dried under the nitrogen line for at least an hour to 
remove the majority of the chloroform.   It was then put on the vacuum line overnight to remove 
the rest of the organic solvent.  Once dry, 0.21 mL of deuterium depleted water containing 
various amounts of NaCl was added to the flask to resuspend the bicelle.  The flask was 
sonicated until the mixture went into solution.  With a Hamilton syringe, the solution was 
transferred to a 5 mm glass cuvette that is 30 mm long and sealed off with HPLC tubing and 
epoxy.  The bicelle sample was then analyzed with P31 NMR to check for bicelle alignment and 
then 2H NMR to compare to the oriented sample splittings. 
 
Results and Discussion 
 
 The first bicelle sample trial was unsuccessful in forming a bicelle.  It was a lipid only 
sample and consisted of DMPC-C14-ester and DHPC-C6-ether.  The sample was lyophilized 
overnight.  Deuterium depleted water was added.  The lipid never appeared to go into solution 
after it was sonicated for 5 minutes and the sample was discarded.   The second bicelle included 
4.  Place oriented sample in 
NMR probe at β = 0 or 90 
2. Add water & stack 
3.  Place in cuvette, 
cap, &  seal 
H0 
β = 0° 
β = 90° 
1. Apply 
peptide/lipid  
 mixture 
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a RWALP 23 (Syn # 610) peptide.  The sample was resuspended in deuterium depleted water 
and sonicated for one hour.  The solution appeared very cloudy which indicated that a lipid 
bilayer has not formed.  It was then put in the heating block for three days and never cleared up 
so it was discarded. 
 The third bicelle was prepared with three lipids.  Zwitterionic (DMPC) and anionic 
(DMPG) ester lipids with 14 carbon chains were combined in a 3:1 ratio with the DHPC-ether 
for a ratio of long (C-14) to short (C-6) lipids of approximately 3.2.  1.32 mL (19.5 µmoles) of 
DMPC-ester, 0.45 mL (6.5 µmoles) DMPG-ester, and 0.07 mL (7.3 µmoles) DHPC-ether were 
combined.  After drying with nitrogen gas, and under high vacuum overnight, the lipids were 
resuspended in 0.120 mL 50 mM NaCl in deuterium depleted water.  After sonication the sample 
was in a slightly cloudy gel in the bottom of the flask.  It was transferred to a 30 mm long glass 
cuvette with a Hamilton syringe and sealed off by inserting one end of a five mm long piece of 
HPLC tubing that had been fused closed; epoxy was then applied to close it off.  The sample was 
analyzed with 31P NMR with a 300 MHz Bruker NMR to check for alignment (Figure 10).  The 
spectrum shows that the bicelle oriented at β = 90 since the peaks are to the right of 0.  The 
larger peaks on the right correspond to the two C14 lipids and the thinner one is the DHPC. 
 
 
Figure 10: Bicelle, DMPC-
ester/DMPG-ester/DHPC-
ether in 50 mM NaCl 
deuterium depleted water, 
 q = 3.56, 31P NMR  
 
 
 
 
 
 
 
 
 
The bicelle sample shown in Figure 10 can be compared to the oriented sample made with only 
DMPC and DMPG (Figure 11). 
 
 
 
 
Figure 11: Oriented sample, 
β = 90, DMPC-ester/DMPG-
ester, 31P NMR, Prepared by 
Rachel Ellis 
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The fourth bicelle trial was lipid only and consisted of DMPC-ester and DHPC-ether.  It 
was resuspended in 100 mM NaCl deuterium depleted water.  After sonicating for several hours, 
the lipids would not go into solution.  The sample was discarded.    
The fifth bicelle trial was lipid only and consisted of 0.613 mL (47.0 µmoles) DMPC-
ether and 0.123 mL (14.0 µmoles) DHPC-ether for a q value of 3.36.  It was resuspended in 
0.210 mL 100 mM NaCl deuterium depleted water and sonicated for two hours.  The solution 
was transferred to a cuvette and sealed.  31P NMR was used to analyze the sample (Figure 12). 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The spectrum shows the lipid-only bicelle was aligned in the β =90 orientation. 
  
The sixth bicelle sample contained 0.613 mL (47 µmoles) DMPC-ether, 0.613 mL (14 
µmoles) DHPC-ether and 7.33 mg (3.05 µmoles) of the peptide KWALP 23, a model 
transmembrane peptide with both Trp and Lysine (Lys) anchoring residues at the carboxy and 
amino ends (Table 1).  The peptide was dissolved and vortexed in 100 μL TFE.  It was then 
added to the lipid solution and then dried.  The bicelle was resuspended with 0.210 mL 100 mM 
NaCl deuterium depleted water and sonicated until it was in solution.  The same sample was 
analyzed using 2H NMR at 313 K (Figure 13) and at 323 K (Figure 14).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13, Bicelle, DMPC/DHPC, KWALP 23,          Figure 14, Bicelle, DMPC/DHPC,  
313 K, 2H NMR, q =  3.36, Syn # 651           KWALP 23, 313 K, 2H NMR, q = 3.36 
 
[ppm]50 0 - 50 
-2
.3
84
3
-1
0.
72
99
- 2
.3
84
3
-1
0.
72
99
DHPC 
DMPC 
[Hz]40000 20000 0 - 20000 
11
52
4.
10
5
57
01
.4
00
0.
00
0
-5
94
4.
00
6
11
52
4.
10
5
57
01
.4
00
0.
00
0
-5
94
4.
00
6
11
52
4.
10
5
57
01
.4
00
0.
00
0
-5
94
4.
00
6
11
52
4.
10
5
57
01
.4
00
0.
00
0
-5
94
4.
00
6
[Hz]40000 20000 0 - 20000 
11
57
9.
10
6
57
04
.4
12
-5
53
4.
12
2
11
57
9.
10
6
57
04
.4
12
-5
53
4.
12
2
11
57
9.
10
6
57
04
.4
12
-5
53
4.
12
2
11
57
9.
10
6
57
04
.4
12
-5
53
4.
12
2
323 K 313 K 
Figure 12: Bicelle,  
DMPC-ether/DHPC-ether, 
100 mM NaCl deuterium  
depleted water, q = 3.36 
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The spectrum of the KWALP 23 bicelle shows more defined peaks when it was run at a 
higher temperature.  There should have been one more pair of peaks since the peptide is triply 
labeled with three deuterated alanines.  The oriented sample containing the KWALP 23 in 
DMPC, created by Anna Daily, is shown in Figure 15.  The two samples are not fully 
comparable because even though the two KWALP 23 peptides share the same sequence, the 
KWALP in the bicelle is labeled at position 7, 9, and 11 while the peptide in the oriented sample 
is labeled at position 13, 15, and 17 so they will have different quadrupolar splittings. 
 
 
 
 The seventh bicelle sample contained 2.39 mL (35.25 µmoles) DMPC-ester, 0.81 mL 
(11.75 µmoles) DMPG-ester, 0.61 mL (14.0 µmoles) DHPC-ether, and 3.0 mg (3.05 µmoles) of 
the peptide Ac-Lfb, a peripheral binding positively charged antimicrobial peptide (Table 1).  The 
peptide was added to the lipid solution as a dry resin.  The mixture was sonicated briefly and 
then dried.  The sample was resuspended in 0.210 mL 100 mM NaCl deuterium depleted water 
and transferred to a glass cuvette for 31P and 2H NMR analysis (Figure 16 and 17).  The 31P 
NMR spectrum only shows one large peak to the right of zero.  In contrast to the lipid alone 
sample prepared with the same three lipids, the short and long lipid peaks are not resolved when 
the peptide is present.  Additionally, the chemical shift of the single peak is shifted closer to 0 (-
10.5 ppm) than same peak for the lipid only sample (-13 ppm).  These results suggest that the 
alignment of the lipids has changed in the presence of the peptide.  For comparison, the 2H 
spectrum of an oriented sample, prepared by Taylor Ladd, containing DMPC-ester/DMPG-ester 
lipids and the Ac-Lfb peptide is shown in Figure 18. 
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Figure 16, 31P NMR, bicelle, 
DMPC/DMPG, Ac-Lfb in 100 
mM NaCl in deuterium 
depleted water, q = 3.36 
Figure 15, Oriented 
sample in DMPC, 
KWALP 23 Syn # 609, 
β = 90, 323 K 
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The quadrupolar splittings (∆νq) of the oriented sample are larger for the oriented 
sample. The largest ∆νq for the oriented sample is approximately 22 kHz and that of the bicelle 
is 9.7 kHz. The splittings for the oriented sample are also better resolved than for the bicelle.   
The eighth and ninth bicelle samples were going to contain the DMPC/DHPC lipids and 
the ATR-tm Native and Trp peptides that were synthesized.  Difficulties were found in inserting 
the peptides into the bicelles.  8.6 mgs (3.05 µmoles) ATR-tm Native and 9.2 mgs (3.05 µmoles) 
ATR-tm Trp were added in their original solutions of HFIP to the lipid solutions.  They were 
dried under nitrogen and left under the vacuum line overnight.  0.210 mL of deuterium depleted 
water was added to resuspend the bicelles.  The bicelles would not go into solution after three 
hours of sonication.  They were heated in a 500C water bath, but the contents remained as a thick 
film.  100 μL of 100 mM NaCl deuterated depleted water was added to each sample to see if 
additional solvent and salt might help to dissolve the peptide in the lipids.  Both peptide solutions 
were put through five cycles of freezing in liquid nitrogen and then 10 minutes in a 500C water 
bath while being vortexed in between [2].  The lipids and peptides were still not going into 
solution and were left in the 370C warm room overnight.   The sample containing ATR-tm Trp 
was slightly less thick and white than the ATR-tm Native, so a lyophilization protocol was 
attempted that has been found to work for incorporating peptides into micelles [4].  First, 300 μL 
of HFIP was added to the thick, white peptide lipid mixture to break up the bicelles. Then nine 
mL of dH2O was added to drive the formation of bicelles, and the sample was vortexed for 20 
minutes.  The solution became clear with a few oily goblets at the bottom.  The solution was then 
frozen in liquid nitrogen and put under high vacuum for two days to lyophilize.  Due to time 
restraints, no further attempts to insert the peptide into a bicelle were made. Repeated 
lyophilizations have been used successfully to incorporate other transmembrane peptides into 
bicelles [2]. 
 The tenth bicelle sample was similar to bicelle sample seven except it was resuspended in 
0.210 mL deuterated depleted water instead of 0.210 mL 100 mM NaCl deuterated depleted 
water.  This was done to see if samples made with water alone would align better than those 
made with salts.  It was made with 1.20 mL (35.25 µmoles) DMPC-ester, 0.81 mL (11.75 
µmoles) DMPG-ester, 0.61 mL (14 µmoles) DHPC-ether and 3 mgs (3.05 µmoles) of the Ac-Lfb 
[Hz]40000 20000 0 - 20000 [Hz]  40000   20000   0  - 20000  
Figure 17, 2H NMR, bicelle, 
DMPC/DMPG/DHPC, 100 mM 
NaCl deuterium depleted water, 
Ac-Lf, q = 3.36 
Figure 18, 2H NMR, oriented sample, 
DMPC/DMPG, Ac-Lfb, β = 90 
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peptide.  The sample was analyzed with both 31P (Figure 19) and 2H NMR. The 31P spectrum 
shows a single peak on the right side of zero very similar to the spectrum for the sample made 
with NaCl (Figure 16).   The spectrum does not show two peaks like the others though for the 
C14 and C6 lipids.  The peak is broad and the peaks could possibly be distinguished if the 
sample was run in a NMR with a bigger magnet.  The 2H NMR did not produce a useable 
spectrum and had a lot of noise. 
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 An oriented sample containing only 80 µmoles DMPC-ester was made.  The lipid was 
resuspended in deuterium depleted water. The sample was cloudy when finished and was placed 
in the heating block.  After two weeks the sample was still cloudy indicating that lipid bilayers 
had not formed.  A second oriented sample also containing 80 µmoles DMPC-ester in deuterium 
depleted water was then made.  The second sample also never cleared up after being in the 
heating block for two weeks.  31P NMR was run and confirmed that the sample had not oriented 
(Figure 20). 
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Figure 19, bicelle, 31P NMR 
DMPC/DMPG/DHPC, Ac-Lfb, 
 in deuterium depleted water,  
q = 3.36 
Figure 20, 31P Oriented 
Sample not aligned, 
DMPC alone in deuterium 
depleted water 
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Conclusions 
 Lipid-only bicelle samples using two to three ester and or ether lipids were successfully 
created and confirmed with 31P NMR.  The peaks were aligned to the right of zero 
corresponding to the β = 90 orientation.  Bicelles with three lipids and a peripheral binding 
peptide (Ac-Lfb) were prepared and were shown to align by 31P NMR.  2H quadrupolar 
splittings of Ac-Lfb in bicelles were reduced compared to those of an oriented sample and 
the peaks were less intense.  2H quadrupolar splittings of KWALP in bicelles were increased 
compared to those of an oriented sample.   An increase in peak resolution was found when 
increasing the NMR temperature from 313 K to 323 K.  The ATR-tm Native and ATR-tm 
Trp peptides were successfully synthesized and confirmed with HPLC and Mass Spec.  The 
ATR-tm peptides were unable to be incorporated into the bicelle samples.  Freeze/thaw 
cycles, lyophilization, heating, vortexing, and sonication failed in try to insert the peptides in 
the bicelle.   Further attempts will be made to use the peptide in the future. 
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The Expression and Characterization of Cytochrome f Mutants in 
Relationship to Cation-Pi Bonds 
Cassandra M. Potter, Oklahoma Wesleyan University 
Bartlesville, Oklahoma 
 
Abstract 
 
In order to better understand not only how the proteins involved in the electron 
transport across the membrane recognize one another, but also how the electron transport 
is performed, we must study the possible determining factors.  What has begun with 
studies on both hydrophobic and an ion-pair interaction involved in the electron transfer 
from cytochrome f to plastocyanin — has now led to the present focus centering upon the 
cation-pi interactions.  Cation-pi interactions involve a positively charged amino acid with 
an aromatic amino acid side chain, and two such interactions have recently been detected 
in cytochrome f.  Because studies on this interaction and its effect on the function and 
stability of cytochrome f have yielded little or no conclusive data at this time, our goal was 
to determine the significance, if any, of the cation-pi interactions on the electron transport 
process that occurs in the photosynthetic relationship between cytochrome f and 
plastocyanin first by site directed mutagenesis, and then by measuring the redox-titrations.   
 
Purpose 
 
 The photosynthetic protein, cytochrome f, plays a key role in one of the most important 
biological processes known — photosynthesis.  Photosynthesis has been adopted by plants from 
photosynthetic bacteria in order to harvest the light energy from the sun.  This underutilized form 
of energy is captured by the chlorophyll contained in plant chloroplasts.  Embedded in the 
membrane of the plant cell, they also contain light-absorbing pigments.  Light absorbed by 
pigments contained in the chlorophyll provides the energy that drives an electron from its ground 
energy level to an excited state and ultimately results in the electron transfer across the 
membrane to an electron acceptor.  This provides the driving force that ultimately — through a 
series of reactions — results in the synthesis of ATP.  Cytochrome f links photosystem I (PSI) 
and photosystem II (PSII) which are the two photon-absorbing sets of pigments involved in the 
electron transfer process of photosynthesis.  Cytochrome f is a part of the cytochrome b6f 
complex, which consists of the following four subunits:  1) 23-kd cytochrome b6 containing two 
b-type heme prosthetic groups, 2) 20-kd Rieske Fe-S protein, 3) 33-kd cytochrome f with a c-
type heme prosthetic group, 4) and 17-kd chain known simply as subunit IV.  These goals will be 
accomplished using various methods; however, at this time, we are making mutants of 
cytochrome f through the method of site-directed mutagenesis.  The synthesized mutants are 
actually “double mutants” because they have two sites that have been altered.  One site alteration 
is meant to make the protein suitable for labeling with ruthenium complexes; and the second 
alternated sites are additional mutations that will either hinder certain properties of the cation-pi 
bond and/or eliminate the cation-pi bond altogether.  These results will enable the determination 
of the specific nature of the two existing cation-pi interactions.   
So far, we have learned from the results of the induced mutation directed at cation-pi 
bond site of each cation amino acid that the kinetic stability was indeed reduced in the C. 
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reinhardtii cytochrome f when compared to the wild type.  However, at this point, it seems as 
though the hydrophobic effect, or the loss there of, caused by the substitutions performed with 
the double mutants is more vital in maintaining the stability of cytochrome f, as oppose to the 
cation-pi interactions.  
Finally, in order to obtain the relative thermodynamic stability comparisons of three 
different cation-pi mutants with wild-type cytochrome f, redox titrations will be performed on the 
six different mutant proteins and the wild-type cytochrome f.  Correlations between these results 
and the kinetic unfolding stability studies will be completed and determined using the UV-Vis 
spectrophotometer and a ferricyanide/ferrocyanide redox couple from which graph will be 
composed from which the visible results can be seen.   
Below are two different views: one of cytochrome f in cytochrome b6f complex and one 
of cytochrome f and plastocyanin. 
 
 
 
 
 
Introduction 
 
Cytochrome b6 f transfers electrons from one photosynthetic reaction center complex 
[more commonly known as photosystem I (PSI)] to the other reaction center complex—
photosystem II (PSII).  PSI reduces NADP+ and PSII oxidizes H2O.  Electron transport via the 
cytochrome b6 f generates much of the electrochemical proton gradient that drives the synthesis 
of ATP in chloroplasts. From the plastoquinone pool, electrons pass through the Cytochrome b6 f 
complex, which occurs through a Q cycle.  Electrons traveling from the terminal electron carrier 
of the cytochrome b6 f complex, cytochrome f, and PSI are mediated by a periphial membrane 
protein located on the thylakoid lumenal surface, which is also known as plastocyanin.  For 
every electron transported, two protons are translocated across the thylakoid membrane.  
Ultimately, the four electrons obtained from 2 H2O by the oxygen-evolving center (OEC) lead to 
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the translocation of 8 H+ from the stroma to the thylakoid lumen.  Below is a simple illustration 
of Cytochrome f at work. 
 
 
  
 
Methods and Materials 
 
First, the proteins were harvested.  This consisted of co-transforming the E.Coli cells with 
plasmids of proteins Alanine, Isoleucine, or Glycine, growing the cultures in Petri dishes to 
express the mutant proteins, and finally harvesting the proteins and preparing them for further 
purification methods such as gel filtration and the HPLC.  Illustrated here are some examples of 
the changes in purification after various methods are performed on the protein.  The first is after 
the protein was put through the HPLC.   
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The product is considered purified when A554/A280 ≤ 0.9 as shown below. 
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Because two specific sites have been determined to contain cation-pi interactions, the site 
directed mutagenesis was exercised at these two points.  The two cation-pi interactions that are 
found in the cytochrome f protein are Lysine 165 / Tyrosine 171 and Arginine 13 / Tyrosin149, 
which are both shown below. 
 
 
 
 
 
 
 
 
 
 Tyr 149  Arg 13 
 Arg 13 
 Tyr 149 
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This figure illustrates the other cation-pi interaction at K165/Y171. 
 
 
  
 The mutant proteins Alanine, Isoleucine, and Glycine were chosen both for reasons of 
similarity and dissimilarity to hydrobicity and size of the amino acid side chains.   
 After purification of the mutant proteins and site directed mutagenesis were completed, 
redox-titrations were performed using ferricyanide and ferrocyanide both on the wild-type 
cytochrome f and on the cytochrome f with mutants Isoluecine, Alanine, and Glycine at Lysine 
165.  The results were a little higher than the wild-type range of 375mV at first, so the buffer 
concentration was altered from 5mM to 100mM; which resulted in the redox-potentials being 
closer to the expected or ideal 375mV for the wild-type, plus or minus about 10 mV.   
 
 
 
 Lys 165 
 Lys 165 
 Tyr 171 
 Tyr 171 
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Results 
 
   The graphs below show the redox-titration data and the minute changes in the midpoint 
potential between the wild-type cytochrome f and the mutants K165I, K165G, and K165A, 
beginning with the wild-type shown below with a midpoint potential of 369mV, following with 
the mutants K165A with a midpoint potential of 365mV, K165I at 357mV, and finally K165G at 
363mV. 
Next is the mutant Lysine 165 Alanine or K165A shown with a midpoint potential of 
365mV. 
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Midpoint potential for Casey K165A #2 Cyt f
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Conclusion 
 
 All in all, after performing the redox-titrations, we found that there were no significant 
signs of change with the mutations in the redox potential of cytochrome f.  This allows the 
conclusion to be drawn that the cation-pi bonds do not affect the oxidation-reduction potential of 
cytochrome f enough to alter the electron transport process, or protein recognition. We did, 
however, find that the buffer concentration does, indeed, have a greater effect on the redox-
potential of a protein than previously thought. Nevertheless, although this data serves as only one 
small piece in the seemingly huge often perplexing puzzle, we hope that its results will open, yet 
another door leading to many more research opportunities on the function and stability of 
cytochrome f.   
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Amine Ligand Exchange Kinetics of Cadmium Selenide 
Semiconductor Nanocrystals 
Christina G. Handford, University of South Carolina - Upstate 
Spartanburg, South Carolina 
 
Abstract 
 Semiconductor nanocrystals have many applications. Among these are biosensors, 
light emitting diodes, and solar cells.1 The size dependent photo luminescent (PL) 
properties play a large part in these nanocrystals applicability to society.2 Cadmium 
selenide is by far the most advanced in terms of research and industrial use today.3 The 
ligands that stabilize the nanocrystal play an equally important roll in these applications.2 
Different ligands allow for the nanocrystal to be dissolved in different solvents. 2 An 
absence of ligand from the system will effectively quench the photo luminescence of the 
nanocrystals, due to oxidation and trap emissions. This research focuses on studying short 
chain n-alkyl amine ligand exchange kinetics of 570-69 nm CdSe nanocrystals. 
 
Introduction 
 In a solution of nanocrystals there are both free ligands in solution and bound ligands 
which are attached to the nanocrystal surface. The ligand, an organic molecule which attaches to 
the surface of the nanocrystal, stabilizes the nanocrystal. Different ligands bond with varying 
strengths to the nanocrystal surface. The strength of the bond is not only related to chain length 
of the ligand, but also to the bonding group.4 An amine bonds to the Cd(II) ions on the 
nanocrystal surface via a dative bond through the lone pair of electrons on the nitrogen atom. 
However, a carboxylic acid ligand participates in a covalent bond between the de-protonated acid 
group and the Cd(II) ions. Much research has been performed on ligand exchange, where one 
ligand is exchanged for another. In such research it is not only important to exchange the ligands, 
but also to conserve the nanocrystal’s luminescence as well. If the kinetics of ligand exchange 
can be determined, this would be very useful in analyzing and performing ligand exchange 
research. 
 
Materials and Methods 
 A concentrated solution of 570 nm CdSe-octadecylamine nanocrystals was obtained from 
NN-Labs. Each sample stock was prepared fresh each day from the concentrated nanocrystal 
solution. In order to prepare the sample, a small volume of the concentrated nanocrystals was 
transferred to a small 8-mL vial and centrifuged. The supernatant was then drawn off using a 
glass pipette, and the nanocrystal pellet was dried with argon. Once dry, ~0.5 mL of hexanes was 
added to the vial, and swirled to dissolve the nanocrystals. The moment hexanes was added, a 
timer was started. The sample stock was made by adding the nanocrystals into a larger volume of 
hexanes, in a 20-mL vial, immediately after dissolution. Once an absorbance (OD) of 0.3 or 0.35 
was obtained, the sample was allowed to equilibrate before amine addition (See Figure 1). 
 
 For each amine solution, enough amine was added to an 8-mL vial to make ~5 mL of 
0.044 M amine solution. The weight of amine added was determined using a balance, and the 
appropriate volume of hexanes was added to the vial using a micro-pipette. Amine solutions 
were prepared for n-butyl amine, octylamine, 2-ethylhexylamine, and 1-aminodecane. 
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 Once the sample stock equilibrated, 2.5 mL, delivered by micro-pipette, was added to a 
glass or quartz PL cuvette. Initial UV and PL spectra were obtained before adding amine. For 
each addition, 0.637 mL of a 0.044 M solution of a particular amine was added. Addition of the 
amine was performed using a micropipette. Immediately after addition, the PL of the sample was 
monitored for approximately 90-100 minutes. In between PL measurements, UV spectra were 
obtained. During measurements, the samples were kept within the dark chamber of the PL 
instrument away from light. UV measurements were taken in a lit room. 
 
 The value of the PL peak intensity was recorded. For data analysis and graphing, the 
intensities were normalized to 1, where 1 was defined to be the intensity of the initial peak after 
amine addition. For graphs showing times of 0-100 minutes, the “0” point is considered the 
moment amine was added, even though the actual addition was performed after 200+ minutes of 
equilibration.  
 
Results and Discussion 
 Precipitation by acetone removes any excess ODA or other solvents. Due to this and the 
concentration change after reconstitution into hexanes, the sample stock needs to be allowed time 
to equilibrate and reach a steady state before addition of amine. However, this is also battled by 
the rate of oxidation occurring on the nanocrystal surface. Therefore, the sample needs to be 
prepared each day. A larger volume can be prepared for use in multiple experiments on the same 
day. Figure 1 shows the results of PL monitoring of Stock Solutions 1 and 2. The rate of decrease 
was constant when the stock solutions were prepared in the same way, even though they were 
prepared on separate days. Figure 1 also shows that stock solutions should be allowed to 
equilibrate at least 200 minutes before addition of amine. 
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    Figure 1: Equilibration of stock CdSe nanocrystal Photoluminescence with time. 
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Figure 2: PL spectra from n-butyl amine addition 
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Figure 3: UV spectra from n-butyl amine addition 
Time 
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 As time increased after amine addition, the intensity of the PL peak increased (Figure 2). 
However, the UV spectra stayed constant (Figure 3). From Figure 2 it can be seen that the PL of 
the CdSe nanocrystals was sensitive to changes on the surface of the nanocrystal. UV-Vis, on the 
other hand, is not affected by changes in the surface of the nanocrystal as shown in Figure 3. 
Therefore, since the absorbance spectra in Figure 3 stayed constant throughout the experiment, 
all changes in PL peak intensity must be due to ligands coming on or off of the surface of the 
nanocrystal. 
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Figure 4: Comparison of PL intensity change after addition of C4, C8, and C10 n-alkyl amines 
 
 
 In initial studies, it appears that shorter chain length amines yield higher and faster 
increases of the PL peak intensity (Figure 4). This could be because the shorter chain length 
ligands are better able to attach quickly to the nanocrystal surface and cover more of the 
nanocrystal surface due to less steric hindrance. There are also indications that the difference in 
chain length and the difference in the final change in peak intensity are directly proportional. 
However, more studies need to be done in order for this to be confirmed. 
  
 It was found to be very important to perform additions within a similar time frame from 
addition of hexanes to the dried nanocrystal sample. Figure 5 shows the dependence of rate and 
amount of increase of photoluminescence on the age of the sample. Samples injected with amine 
at the same time yielded similar results. However, if injections were performed at different times, 
the results were no longer the same. This was due to oxidation occurring on the surface of the 
nanocrystal. The oxidation removed suitable binding sites, therefore altering the kinetics of the 
system. 
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Figure 5: Time dependency of results using 2-ethylhexyl amine for additions 
 
 
Conclusion 
 The kinetics of amine ligand exchange can be successfully monitored via PL 
measurements. This is shown by the UV spectra staying the same while the PL spectra change 
with time after addition of amine. Along with successful monitoring of ligand exchange, the 
importance of the timing of addition has also been shown. Since oxidation of the nanocrystal 
surface occurs readily, the injection needs to be made at a regular time in order for results to be 
reproducible. Also, a trend has been shown between the rate/amount of increase in PL intensity 
and the chain length of the amine ligand added. Due to less steric hindrance, the shorter chain 
amines are better able to cover and attach more quickly to the nanocrystal surface. 
 
Future Work 
 The experiments performed in this research have allowed for development of a method 
for monitoring the kinetics of the amine ligand-CdSe nanocrystal system that yields reproducible 
results. By carefully timing additions of amine, adding the same molar amount of amine, and 
making sure the OD of a sample is the same, the method was developed. Now, more experiments 
need to be performed in order to determine kinetics equations of these systems. Experiments that 
would need to be performed in the future are: 
•  Additions of varying amine concentrations. 
•  Successive addition of amine until the nanocrystal system is saturated and an increase in 
PL is no longer seen. 
•  Determination of a method to add longer chain amines, which was prevented in these 
experiments due to low solubility in hexanes at room temperature. 
•  Addition of amine to nanocrystals of varying size. 
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These experiments would allow for determination of kinetics equations that would be useful to 
the scientific community in designing, implementing, and analyzing new research. 
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Exploring New Ligands for Negishi Cross-coupling Reactions 
Beth Hilburn, Arkansas Tech University 
Russellville, Arkansas 
 
 
Abstract 
 
 The most versatile conceivable method for forming a new C (sp3)-C (sp3) bond in an 
organic molecule is by performing a metal-catalyzed cross coupling reaction with an alkyl 
nucleophile and an alkyl electrophile. If reliable asymmetric methods of this reaction could 
be developed, it could revolutionize the way drugs and materials containing C (sp3) 
architectures are made. Negishi cross-coupling reactions are performed using a variety of 
ligand-metal-halide catalysts to form these new bonds.  
 
 
Introduction 
  
 Many drugs are chiral compounds that can either be of the R or the S configuration in 
organic chemistry. The human body can often only digest either the R or the S, but not both, 
configuration of some of these compounds, or one configuration may be toxic while the other of 
the same compound may help ease discomfort. For instance, the body can digest lactic acid 
found in milk, but it cannot digest the lactic acid that builds up in muscle tissue. Therefore, 
pharmaceutical companies go to great lengths to produce enantiopure compounds (only of one, R 
or S, configuration). This can often involve several time and money consuming steps.  
 Dr. David Vicic’s lab at the University of Arkansas is working on synthesizing ligands to 
attach to metals to use as catalysts in Negishi cross-coupling reactions to form C (sp3) – C (sp3) 
bonds to produce some of the above mentioned enantiopure compounds. If reliable asymmetric 
methods of this reaction could be developed, they can be used by pharmaceutical companies 
among other industries to produce enantiopure products in fewer steps, thus saving them time, 
materials, and money, in turn possibly making consumer products less expensive and more 
available.  
 The ligand attached to the metal catalysts can be changed or altered to produce the best 
yields of the product. Generally, the larger the ligand the better it is. This is because a large 
ligand can take up space around the metal and prevent unwanted side reactions such as the beta-
hydride reactions that are common when using transition metal alkyls. The ligand blocks specific 
quadrants around the metal guiding the incoming molecule to bind to the same site on each 
complex in the solution producing the enantiopure compound.  
 In the past, the ligands like the examples in Figure 1 below have been successfully 
synthesized and used for Negishi cross-coupling reactions in the Vicic group. For this project, 
attempts were made to do the same with ligands 3, 4, 5, 6, and 8 in Figure 2 below.  
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 The ligand is attached to the metal catalyst (see Figure 6) which can be altered to best 
suit the cross-coupling reaction to produce the greatest yields.  The catalytic cycle for cross-
coupling can possibly occur as described in scheme 1 below.   
 
 
 
Scheme 1 
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 We are also pursuing the synthesis of the air-stable di-iodide 7.  Having a pre-formed 
catalyst might increase the yields of the cross-coupled product.  We believe this complex has 
been synthesized, and now we are attempting to grow crystals so we can characterize the 
complex by X-ray crystallography.  (See Figure 3 below for the setup for growing the crystals.)  
 
 
 
 
Compound Dissolved
         in DMSO
ether
The vapor of a solvent the material is poorly soluble in is slowly 
diffused into the solution conataining the product with the desire to 
force crystalization  
Figure 3 
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Results 
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Figure 8 – Compound (2) 
 
 
 
 
 
 
 
Figure 9 – Ligand (3)
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Figure 10 
 
 
 
 
Discussion 
 
 The synthesis of compound (2) and ligand (3) were successful with good yields (see 
Figure 4). There purity can be seen in their NMR spectra (figures 8 and 9 respectively).   
Some product was formed in the synthesis of ligand (5), but could not be purified. In one 
attempt to make (5), some product was detected by TLC but could not be isolated by column 
chromatography using the solvent system in the literature (9:1 CH2Cl2/MeOH). After six 
columns were run on the same sample trying different ratios of the solvent and triethylamine and 
using a bigger column, diethyl ether was found to better separate the components (starting 
material, product, and benzyl bromide). By the seventh column using the ether however, there 
was concluded to be no product left to isolate. The reaction was attempted again on the same 
scale, but could not be pushed to completion and did not show much product by TLC. Also, there 
were five unknown spots on the TLC plate one of which should’ve been the product. It was not 
identified which of these spots was the product. Even using the ether as the solvent, it was 
concluded that each spot could not be isolated to be characterized. An attempt was made to 
synthesize ligand (8) using (3) and heptyl-Iodide following the same procedure as that for (5) 
which also failed to yield product (see Figure 5). 
All attempts to make ligand (4) failed yielding two spot by TLC. It was concluded that by 
using the solvent system from the literature (10:1 CH2Cl2/MeOH) plus triethylamine the spots 
could not be separated and characterized. While (3) was easily synthesized, it was believed that 
(4) was more difficult due to the difference in electronic effects of the phenyl- and cyclohexyl- 
groups on the diamine species. Since the phenyl- group would donate less electron density to the 
amine than the cyclohexyl- group, the amine would have more difficulty attacking the carbon on 
the imine on (2).  
Attempts to test (3) in the Negishi coupling reaction failed (see Figure 7). No product 
was observed by GC at 11.8 minutes (see Figure 10).  Attempts were made as well to grow a 
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crystal of the I2-Ni-ligand (7) (see Figures 6 and 3 for reaction scheme and setup) but were not 
completed due to lack of time. Further attempts will be made in the Vicic lab.   
 
 
Experimental 
 
 
Preparation of Pyridine-2,6-dicarboximidic acid diethyl ester (2): To pyridine-2,6-carbonitrile 
(1) (5.3659 g, 41.6 mmol) in anhydrous MeOH (100 ml), Na (123.2 mg, 5.36 mmol) was added. 
After stirring for 44.5 hours at room temperature under N2, HOAc (300 µl, 5.25 mmol) was 
added and the solvent removed under reduced pressure. (2) was obtained as a tan powder (8.09 g, 
100%) and was used directly for further reactions.  
 
Synthesis of 2,6-Bis-([3aR,7aR]-3a,4,5,6,7,7a-hexahydro-1H-benzoimidazol-2-yl)-pyridine (3): 
(2) (1.6095 g, 8.33 mmol) and (R,R)-1,2-diaminocyclohexane (2.6427 g, 23.1 mmol) were 
weighed into a 100 ml two neck flask. Dichloromethane (20 ml) was added to the flask. After the 
resulting mixture was stirred at refluxing temperature for two days under N2, the reaction was 
quenched with water (≈20 ml) and the organic layer was extracted with dichloromethane (≈10 ml 
x 3) and dried over MgSO4. The solvent was removed under reduced pressure to yield a tan 
solid, which was purified by crystallization (ethylacetate) to give (3) as a white shiny solid 
(1.8105 g, 67.2%). 
 
 
 
Conclusion 
 
 
 While only the synthesis of (2) and (3) were the only successful reactions in this project, 
further attempts will be made in the Vicic lab at U of A to synthesize new ligands for the Negishi 
cross-coupling reactions. The attempt to grow a crystal of the I2-Ni-ligand (7) was still underway 
as of the writing of this paper. 
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Production and Study of Amino Acid Mutations at the  
Cytochrome C Binding Site 
Zakiya Japera Hoyett, Norfolk State University 
Norfolk, Virginia 
 
Abstract 
 
 
 The purpose of this research was to study the rate of electron transfer by cytochrome c in 
the mitochondrial respiratory chain.  Cytochrome c transfers electrons between Q-cytochrome c 
oxioreductase and cytochrome c oxidase; however, this transfer occurs so rapidly that it is very 
hard to observe.  In this experiment, lysine 13 of horse cytochrome c was mutated, grown, and 
purified; lysine 13 was chosen because it is a key binding site between cytochrome c and 
cytochrome c oxidase.  The binding activity of the mutants was compared to the binding of 
native cyctochrome c by steady-state enzyme kinetics.  Using UV-visible Chemstation Software, 
we attempted to determine and compared the KM and Vmax of the native cytochrome c to each of 
the mutants.  The results proved that the mutants had a huge affect of the rate of transfer, 
however, and accurate KM and Vmax could not be determined.   
 
 
Background and Introduction 
 
 
 All organisms require energy to live.  The mitochondrion is the major source of 
adenosine triphosphate (ATP) in aerobic organisms.  The mitochondrial respiratory chain 
produces most cellular energy by the transport of protons across the inner mitochondrial 
membrane.  This is caused by the electron flow within three large protein complexes called 
NADH-Q oxidoreductase (Complex I), Q-cytochrome c oxidoreductase (Complex III), and 
cytochrome c oxidase (Complex IV). (1) 
 
Figure 1 Mitochondrial Respiratory Chain  
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Cytochrome c (Cyt c) is the only cytochrome in the mitochondrial respiratory chain that is not 
bound tightly to the membrane making it the easiest protein to isolate in pure form.  The 
responsibility of Cyt c in the chain is to receive electrons from complex III and then transfer 
them to complex IV. (2) However, the mechanism by which this transfer occurs is still not 
completely understood.   
According to Smith, Ahmed and Millett, the positively charged amino groups of lysines 
surrounding the heme crevice of Cyt c are involved in the interaction between it and complex IV.  
These include lysines 8, 13, 72, 86, and 87. (3)   The rate of the reaction and the strength of the 
bind are highly dependent upon these lysines and studies show that chemical modification of 
these lysines significantly increase the KM value for the steady state reaction. (4) 
In this research, lysine 13 (K13) of horse heart Cyt c was mutated, rather than being 
chemically modified.  The goal was to observe the effect of changing this positive binding site, 
AAA, to a negative binding site and a neutral binding site.  The K13 mutants were intended to act 
as “binding inhibitors”.  Mutant K13A, GCA, made a neutral binding site and mutant K13E, 
GAA, made a negative binding site.  Successful growth of either mutant would result in a 
weakened bond between Cyt c and complex IV.  The mutants could then be used in steady state 
kinetics to determine the Vmax and KM of the mutants to see what effect they have on the rate of 
electron transfer of Cyt c.   
 
Figure 2 Horse Cytochrome C  
 
 
Experimental Procedures 
 
 
 Forward and reverse primers of K13E and K13A constructed from the known gene 
sequence were obtained from Integrated DNA Technologies (IDT).  Protocol of Stratagene’s 
QuikChange® II Site-Directed Mutagenesis was performed using the IDT primers.  From the 
resulting colony growth, four colonies were picked from the agar plate and dropped into a culture 
tube filled with broth and ampicillin.  After overnight incubation, the procedure of Promega’s 
Wizard® Plus Minipreps DNA Purification System was carried out and a 20 micro liter aliquot of 
each plasmid prep was sent to the DNA Sequencing Lab of the University of Arkansas.  
 After receiving the results confirming a successful mutation of both K13A and K13E, the 
plasmids were used for the growth and expression of more of the mutant protein.  When both 
mutants had been harvested, they were purified, concentrated, and washed in 5mM sodium 
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phosphate buffer pH 7.   The samples were then separated by the Waters High-Performance 
Liquid Chromatography (HPLC) using the Millennium software.  To further purify, each sample 
was re-washed and run through the Hitachi HPLC using the EZChrome Elite software. 
 
 
 
 
Figure 3 Chromatogram readings from HPLC purification for K13A (top) and K13E (bottom) 
 
 Confident that the most purified form of each mutant had been collected, the end result 
was concentrated.  A solution of Native Horse Cyt c was prepared and the concentrations of all 
three solutions were determined using the Agilent spectrophotometer and the UV-visible 
Chemstation Software.  Using the three solutions as stock solutions,   the binding activity of the 
mutants was compared to the binding activity of native cyctochrome c by steady-state enzyme 
kinetics.   
 
 
Results 
 
 
To test the binding activity of the mutants, various assays of steady-state enzyme kinetics 
were completed comparing the activity of the mutants to that of native horse cytochrome c.  Each 
time the procedure was modified in hopes of retrieving more accurate results.  However, it was 
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determined that in order to make a precise graph from which to retrieve defined values for KM 
and Vmax, a very concentrated sample of both mutants had to be used.  Even so, Beer’s Law 
states that if A = 2.00, then 99% of the photons passing through the sample are absorbed and 
only 1% reach the detector.  Thus, any concentration of an absorbance greater than 2.00 is 
obsolete and therefore cannot be used.  Hence, the reason for so little data collection of both of 
the mutants.   If time had permitted enough sample had been made, the oxidase concentration 
could have been adjusted to perhaps achieve better results.   
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Figure 4 Eadie-Hoffstee plots of steady-state array results 
 
 
Based on earlier data, it was assumed that Vmax for all samples remained constant at 0.0122 sec-1.  
The KM of Native K13 was -9.1628µM; K13A was approximately -148.28 µM; and K13E was 
approximately -184.37µM. (5) 
 
 
Discussion 
 
 
Figure 5 Michaelis-Menten Model accounts for the kinetic properties of most enzymes (1) 
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 All the recorded results are recorded are based on the equation seen above. KM, the 
Michaelis–Menten constant, and Vmax, the maximal rate of reaction, are derived from that one 
equation.  The KM is important to know because, primarily, it provides a measure of the substrate 
concentration required for significant catalysis to occur.  Secondly, in certain conditions where 
kcat is much smaller than k-1, KM is a measure of the strength of the ES complex: a high KM 
indicates weak binding and a low KM indicates strong binding.  Vmax indicates the point at which 
the reaction is making ES as fast as ES changes to E and P; the point at which ES is fully saturate 
with S. (1) 
 In previous studies of chemically modified cytochrome c derivatives, enzymatic activity 
was measured using an oxygen electrode rather than absorbance changes.  The results showed a 
minor change in Vmax but a fivefold and even a tenfold change in KM. (5) Aiming to compare 
these past studies with this research, the Vmax in this research was assumed to remain constant; 
this resulted in 15-16% increase in each mutant, indicating that the mutated K13 might have a 
greater effect in binding than the chemically modified K13; they were expected to be about the 
same.  Only further studies with more specific results can verify just how great of an impact 
mutating has on binding.   
 
Conclusion 
 
 
 The growth of mutated horse heart cytochrome c was proven possible.  Steady-state 
kinetics studies also confirmed that the mutating of K13 had the same effect on the binding 
activities at this site that chemical modification in previous studies had; however, these results 
suggest that mutating K13 has a greater affect on the KM than in chemical modification.  In 
future studies involving these mutants, the binding may be measured using the ultracentrifuge if 
the absorbance factor does not induce restrictions.  The mutants can also be used as inhibitors in 
laser studies of binding in the mitochondrial respiratory chain, allowing a more distinct analysis 
of the effect the DNA change has on electron transfer between cytochrome c and cytochrome 
oxidase.    
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Abstract 
 
 Thrombomodulin is thought to be a key regulatory protein in blood coagulation due 
to its activities when bound to the protein thrombin.  The thrombin-thrombomodulin 
complex both breaks down blood clots by inhibiting thrombin activity and activating 
protein C and also stabilizes blood clots by activating thrombin activatable fibrinolysis 
inhibitor.  A key amino acid involved in the binding of thrombomodulin to thrombin is 
methionine 388.  This research project attempted to sequence the gene for thrombomodulin 
in two mammalian species, pig and cat.  Both nondegenerate and degenerate primers were 
designed using several different methods.  These primers were used to amplify sections of 
the gene for thrombomodulin using the polymerase chain reaction.  Products of these 
reactions were analyzed using gel electrophoresis.  Several individual degenerate primers 
were found to act in both the forward and reverse directions in some area of certain 
genomes to produce a fragment of similar length to what was expected from the primer 
pairs.  The nondegenerate primer sets were more effective in amplifying areas of the 
genome than the original degenerate primer sets.  However, their products were not 
specific enough to be used for sequencing.  Only a few of the web-designed primers have 
been used at this time.  Further research will include the further testing of primers as well 
as the varying of the reaction conditions to increase specificity.  Once specific DNA 
fragments are produced, these fragments can be sequenced, and the sequences can be 
analyzed to determine the presence and location of MET388.  
 
Introduction 
 
 Thrombomodulin (TM) is a transmembrane glycoprotein found on the surface of 
endothelial cells lining blood vessels and is thought to be a possible key regulatory protein in 
blood coagulation.1  TM forms a 1:1 complex with thrombin, the major product of the 
coagulation cascade.  This complex produces two anticoagulant effects.  First, this binding 
removes thrombin from the coagulant pathway.  When unbound by TM, thrombin activates 
platelets and other cofactors involved in the formation of blood clots.1  Thrombin also cleaves 
fibrinogen to make fibrin, which forms the blood clot’s framework.1  By binding to thrombin, 
TM prevents thrombin from assuming its normal role in coagulation.  The second anticoagulant 
effect of the binding of thrombomodulin to thrombin is the initiation of the anticoagulant 
pathway due to the activation of protein C by this complex.  Activated protein C acts as a 
protease to degrade several of the cofactors involved in coagulation.2  In addition to these two 
anticoagulant effects, the thrombin-thrombomodulin complex also stabilizes blood clots.  The 
complex has been shown to be a potential activator of thrombin activatable fibrinolysis inhibitor 
(TAFI), an enzyme that potently inhibits the cleavage of fibrin.3  Therefore, thrombomodulin is 
involved in both the breakdown and the stabilization of blood clots suggesting that it is a 
regulatory protein.   
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 TM contains six epidermal growth factor (EGF)-like regions in its extracellular domain.1  
The last three of these regions are known to be the area that actively binds to thrombin, and the 
short linker between the fourth and fifth regions has been shown to be especially important.4  
This linker usually contains three amino acids, one of which is methionine 388 (MET388).  If 
this specific methionine is changed in any way except by being converted to luecine, the binding 
activity of TM to thrombin drastically decreases.  Specifically, oxidation of MET388 to 
methionine sulfoxide produces a 90% decrease in the cofactor activity of TM.4  It is thought that 
MET388 inserts itself into the hydrophobic core of the fifth domain, pushing out several key 
thrombin binding residues and improving TM's binding affinity for both thrombin and protein C.  
When oxidized, MET388 is not able to insert itself into the hydrophobic core of the fifth domain, 
and TM does not bind as readily to thrombin or to protein C.4  However, it has recently been 
shown that oxidation of MET388 does not affect the activation of TAFI by the thrombin-
thrombomodulin complex.5  Therefore, oxidation of MET388 in TM inhibits its coagulant 
downregulation abilities while not affecting its clot stabilization abilities, creating a 
prothrombotic environment in the vascular system, which causes an increased risk for heart 
attack and stroke.   
 Cardiovascular diseases, especially heart attack and stroke, are known to be the most 
common cause of death in smokers.  An important factor in these diseases is the increased ability 
of the blood of smokers to clot easily.6  Increased oxidative stress on the body is one of the many 
harmful conditions caused by tobacco smoke.7  This high oxidative stress in smokers is known to 
cause increased oxidation of two key methionines in α1-antitrypsin, which leads to emphysema.8  
However, the connection between the high risk of cardiovascular disease in smokers and 
increased MET388 oxidation in TM has not been well established. 
 MET388 is conserved in several mammals including mice, humans, cows, and 
chimpanzees.  The conservation of this specific methionine in the TM of all of these mammals is 
evidence of both its importance to the function of this protein and the ability of TM to act as a 
regulatory protein.  However, this evidence is weak due to the small number of mammals in 
which the gene sequence of TM is known.  My objective in this research is to increase this 
evidence of the significance of MET388 to the function of TM by sequencing the gene for TM in 
two mammalian species, pig and cat.   
 
Materials and Methods 
 
 In house primer design.  Previous work included designing primers by aligning the 
known TM gene sequences and determining short segments (20-25 bases) where there was a 
very high rate of conservation.  Since the gene for TM is relatively large, it was divided into five 
overlapping sections, and degenerate primer pairs were designed for each section.  The area of 
the gene thought to code for MET388 was included in two sections to increase the accuracy of 
the sequence information obtained.  Due to the lack of any prior knowledge of the TM gene 
sequence in the animal genomes being studied, several alternate sections were designed along 
with degenerate primer pairs for these sections.  Also, nondegenerate primer pairs specific to the 
human, dog, and mouse TM gene sequences were designed corresponding to the original 
sections.  All primers were obtained through Sigma-Genosys. 
 Web-based  primer design.  Two world wide web programs were used to design pairs of 
primers useful for amplifying regions of genomic DNA where prior sequence information was 
not known.  First, the CODEHOP designer (http://blocks.fhcrc.org/codehop.html)9 compared 
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aligned protein sequences and determined blocks of highly conserved amino acids.  From these 
blocks, consensus-degenerate hybrid oligonucleotide primers (CODEHOPs) were designed 
consisting of a 3’ degenerate core region and a 5’ nondegenerate clamp region.  Second, the PriFi 
designer (http://cgi-www.daimi.au.dk/cgi-chili/PriFi/main)10 used an alignment of the DNA 
sequences from several related species to determine possible degenerate primer pairs. 
 PCR and gel electrophoresis.  For each reaction, 100 ul of reaction mix was made 
according to Table 1.  Genomic DNA was obtained from Novagen, and the nucleotide mix was 
obtained from Promega.  Biolabs was the source for the polymerase and its buffer.  Reagents 
were all added to sterile 0.2 mL PCR tubes in the order shown in Table 1.  A RoboCycler 
ThermoGradient 96 thermocycler with a heated lid was used to conduct all reactions.  The cycle 
determined to be the most effective is shown in Table 2 with the annealing temperature varying 
according to the melting temperature of the primers being used.  In general, the annealing 
temperature was set to 5-10° C below the lowest melting temperature.  If no results were 
produced, the annealing temperature would be systematically lowered until 45° C was reached 
and still no results were produced.  If the initial results were nonspecific (i.e., smearing or 
multiple bands), the annealing temperature would be increased until either more specific results 
were produced or the melting temperature was reached.  Negative controls were run with most 
reaction sets by mixing all reagents in Table 1 except the template DNA.  Gel electrophoresis 
was conducted on the products of the PCR reactions.  A 1% agarose gel was used in 1X TAE 
buffer (pH of 8.0), and the DNA was stained using either ethidium bromide or SYBR Green I for 
nucleic acids.  The gels were run at 82 V for approximately 45 minutes before analysis using 
either a UV illuminator or an orange filtered light.      
 
Table 1.  PCR reactants and concentrations 
for 100 μL reaction mix. 
Reactants Final Concentration 
PCR buffer 1X 
MgSO4 (in buffer) 2 mM 
dNTP’s (each) 200 μM 
Primers (each) 100 pmol 
Template DNA 75 ng 
Polymerase 1 unit 
 
Table 2.  Optimal PCR cycle determined by use of positive control. 
Number of 
cycles 
Type of step Temperature Time (minutes) 
1 Initial Denaturation 95° C 2.0 
30 Denaturation 95° C 0.6 (35 seconds) 
 Annealing variable 0.6 (35 seconds) 
 Elongation 72° C 0.6 (35 seconds) 
1 Final Elongation 72° C 10.0 
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 DNA sequencing.  Once the PCR reactions produced a band of interest, this band was cut 
out of the gel with a razorblade, and the DNA was purified using the MinElute Gel Extraction 
Kit from Qiagen.  The final concentration of DNA extracted from the gel was measured using a 
fluorometer.  Two microcentrifuge tubes were prepared each with the concentrations of one 
primer (5’ or 3’) and DNA specified by the University of Arkansas' DNA sequencing lab.  
 Positive controls.  Since a partial sequence of the TM gene in cattle is known, this 
sequence was used as a positive control.  Specific (nondegenerate) primers were designed in the 
same sections of the sequence used to design the degenerate primers.  These primers were 
reacted with Bovine genomic DNA using the same procedure as described above for the 
degenerate primers.  Also, nondegenerate primers for a section of the LDH gene in cattle were 
obtained and used as another positive control.   
 
Results and Discussion 
 
In house degenerate primer sets.  At the lowest possible annealing temperature (45° C), 
none of the original degenerate primer sets gave reproducible results.  Two of the sets gave PCR 
products with multiple bands on the first attempt.  However, when these PCR reactions were 
repeated, no bands appeared on the gel at all.  It was hypothesized that the samples were not 
being consistently heated to the correct temperature.  The hinge on the thermocycler’s heated lid 
was broken but had been taped using aluminum tape.  However, the lid would not remain latched 
down to keep it in close contact with the samples.  Nondegenerate primers specific to cow TM 
were then used as a positive control to determine if product would be made both when the lid 
was left alone and when the lid was constantly held down close to the samples.  No bands were 
seen for PCR samples when the lid was left alone.  However, when the lid was held down 
constantly, the positive control samples produced the expected single band around 350 base pairs 
(bp).  Therefore, the broken heated lid of the thermocycler was causing the samples to not be 
consistently heated to the correct temperature.  For all further experiments, the lid was held down 
during the cycling process.   
 After this, PCR reactions using all sets of the original degenerate primers were repeated.  
All but one of these sets gave no results with pig, cow, or cat template DNA.  One primer set 
produced multiple bands ranging from 400-900 bp even when the annealing temperature was 
increased to close to the melting temperature of the primers.  Since the fragment length was 
predicted to be between 400 and 500 bp, the band closest to this length was excised from the gel, 
and the DNA was extracted and sent to the sequencing lab.  However, the results of the 
sequencing showed that one primer gave double sequence information and the other primer gave 
no signal at all.  New primer dilutions and samples were made and submitted, but the results 
were the same.  A PCR reaction was done using each primer individually and comparing these 
results with the reactions done using both primers.  The results of this test showed that one of the 
primers involved produced the same results individually as were shown for both primers 
together.  Therefore, these individual primers were acting in both the forward and reverse 
direction in some area of the genome to produce a fragment of similar length to what was 
expected.   
 Since no results were produced when primer sets for each section of the TM gene were 
used, the 5’ primers from each set were reacted with the 3’ primers from other sets.  The only 
results produced were from the PCR reaction involving cow template DNA with one cow 
specific primer and one degenerate primer.  However, due to a test that used the individual 
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primers and showed that the cow specific primer gave the same results as both primers together, 
these results were dismissed as produced by the cow specific primer acting in both the forward 
and reverse directions. 
 Alternate degenerate primer sets designed according to similar sections of the TM gene 
were tested with the same reaction conditions as for the previous degenerate primer sets.  Four 
out of the five sets reacted with both pig and cat genomic DNA gave no results.  One of the sets 
produced multiple bands with some smearing in between on the gel when reacted with both pig 
and cat genomic DNA.  However, the bands were indistinct and raising the annealing 
temperature did not reduce either the number of bands or the level of smearing.  The 5’ alternate 
primers were also reacted with the 3’ alternate primers of other sets using pig genomic DNA.  In 
some reactions, a strong band was seen having a size of below 50 bp.  The minute size of this 
fragment suggests that it is merely dimerized primers.  No other distinct bands were produced in 
these reactions. 
 Nondegenerate  primer sets.  Nondegenerate primer sets designed according to the same 
sections of the TM gene as used for the degenerate primers were tested using the same reaction 
conditions.  The human specific primer sets tested with cat genomic DNA showed no distinct 
bands but quite a bit of smearing.  This smearing could be masking some distinct bands.  When 
the human specific primers were tested with pig genomic DNA, one set produced a fragment of 
similar size to what was expected with some smearing around it.  The band was cut from the gel, 
and the DNA was extracted and sent to the sequencing lab.  Results of the sequencing 
experiments showed that the extracted DNA looked like a mixture of multiple fragments, giving 
a very low signal and no good sequence information.  It was suggested that this was due to the 
smearing around the band that was excised from the gel.  The other sets of human specific 
primers tested with pig genomic DNA also showed some very distinct bands.  However, these 
bands were very large compared to the expected size of the fragments and were not extracted 
from the gel. 
 Three of the primer sets specific to the dog TM sequence and three of the primer sets 
specific to the mouse TM sequence were tested with pig genomic DNA.  One of the dog specific 
sets and all three of the mouse specific sets gave only some smearing, while the other two dog 
specific sets gave strong single bands near the expected size of the fragments.  However, again, 
there was also some smearing around these bands that inhibited the possibility for good 
sequencing results.   
 Positive controls.  Nondegenerate primers specific to the known cow TM sequence were 
tested using the same reaction conditions as used for the other primer sets.  The first set of 
specific primers used produced a band on the gel with a similar size to what was expected.  To 
test our methods of extraction, the band produced was excised from the gel, and the DNA 
extracted and sent to the sequencing lab.  However, the results of the sequencing showed that one 
primer gave double sequence information and the other primer gave no signal at all.  Since a test 
of one of the cow specific primers had shown that it acted in both the forward and reverse 
directions, this primer set was dismissed as a positive control.  Another primer set specific to the 
cow TM sequence was used to test the PCR reaction conditions.  This set produced a single band 
with some smearing around it.  The extracted DNA was sent to the sequencing lab, but the 
results showed that the DNA was a mixture of fragments due to the smearing around it.  Finally, 
nondegenerate primers specific to the LDH gene in cattle were obtained from the University of 
Arkansas Animal Science laboratories and used to test our reaction conditions.  These primers 
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produced a very clear single band of the same size as was expected, showing that our reaction 
conditions were correct. 
 Web-based degenerate primer sets.  Several of the CODEHOP designed primers were 
tested using pig genomic DNA.  However, most of the primers tested gave no bands at all when 
run on the gel.  A few of the primers gave some light smearing, but no distinct bands were 
visible.   
 
Further Research 
 
 The next step of this research will consist of testing all of the web-based primers with 
both pig and cat genomic DNA.  If no specific bands are produced, both degenerate and 
nondegenerate primers showing some smearing or multiple bands should be retested changing 
such reaction conditions as annealing temperature, cycle times, and reactant concentrations in 
order to increase the specificity of the primers.  When specific bands are produced and good 
sequence results obtained, the sequences can be analyzed to determine the presence and location 
of MET388. 
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Carrie Peter, John Brown University 
Siloam Springs, Arkansas 
 
Introduction 
 
Soft corals, also known as octocorals, have been consistently studied due to their unique 
structure and impressive biological activity of their secondary metabolites.1 The eunicellin 
diterpenes are a large family of metabolites isolated from octocorals that possess an 
isobenzofuran ring system (scheme 1). Many of the eunicellin diterpenes have been found to 
have potent activity against cancer cells, but no way has been designed to synthesize these 
compounds efficiently and many simply have not been assayed for their biological activity. The 
McIntosh group is currently working on the synthesis of sclerophytin A (scheme 1), which has 
demonstrated a strong cytotoxicity of  1.0 ng/mL against the L1210 leukemia cell line.2 We are 
developing a method to quickly and economically produce a parent compound that is a 
simplified analog of sclerophytin A. The structures we have produced has functional groups that 
can be diversified so that a directed library of the different analogs can be made and their 
cytotoxicity assayed. Then, structure-activity studies can be done to guide the synthesis of future 
analogs. 
 
                            Scheme 1 
H
H
OH
H
OH
HO
sclerophytin A
H
H
OH
H
isobenzofuran  
 
Background 
 
 Very little is known about what makes sclerophytin A biologically active. As a result, the 
rational synthesis of simplified analogs of the compound that are also active is not possible at 
this time.  By identifying parent structures that are active, we will be able to create a library that 
contains many analogs of these parent structures. Then, by assaying these compounds and 
analyzing the results, the characteristics that contribute to the cytotoxicity can be established. 
 The McIntosh group has previously synthesized several isobenzofuran  compounds that 
and found that a 2-bromobenzaldehyde on a tertiary alcohol isobenzofuran structure 
demonstrated a very promising IC50 of 20 μmol/L against the KB3 cell line (scheme 2). This 
activity is good, but we hope to see it decreased by a factor of 102 or 103. Other analogs with 
varying activities were produce; the reason behind their varying activities has not been 
established (scheme 3). 
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                Scheme 2 
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         Scheme 3 
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To produce the isobenzofuran analogs, the McIntosh group has developed a 
cycloaldolization reaction (scheme 5).3 Because the group has already found a promising 
structure, the next step is to work with the general tertiary alcohol structure to make more 
compounds and compare their activities (scheme 4). Then, what characteristics of the structure 
make it biologically active can be determined and efficient ways to vary the ester and aryl 
functional groups produced in hopes of finding more active compounds.  
                    
                                 Scheme 4 
                                                
O
X
HO
H
EtO2C
general analog  
                           
Using Cycloadolization with the 3-bromobenzaldehyde 
 
 Because the tertiary alcohol analog showed such a strong cytotoxicity similar analogs of 
the structure were made to see if they would also exhibit activity. We investigated the effect of 
the position of the Br substituents by employing 3-bromobenzaldehyde to make the 
isobenzofuran product. The mechanisms used were identical to those that made the 2-
bromobenzaldehyde product. Research done by other groups showed that a glycolate ester could 
undergo a selective enolization with cyclopentenone.1, 4 The McIntosh group tried a similar 
procedure for the cycloaldolization of a glycolate and was successful. First, the anti-aldol was 
made by adding LDA to the (S)-(+)-carvone. The LDA served as a strong base to deprotonate the 
alpha hydrogen on the (S)-(+)-carvone so the 3-bromobenzaldehyde could attach itself to make 
the anti-aldol. Acetic acid was added to quench the compound and form the alcohol on the aldol. 
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Then, using an etherfication mechanism 2,6-lutidine was used to deprotonate the alcohol so 
EtO2C could bond to the oxygen forming a glycolate.3  The glycolate was then easily 
transformed into the isobenzofuran structure through the cycloadolization by adding KHMDS, 
which deprotonated the EtO2C and caused the isobenzofuran to form. All the reactions ran fairly 
smoothly to finally yield a beige, powdery crystal solid as the cycloaldol.      
 
 Scheme 5 
 
O OH
O
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3. AcOH
Ag2O
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O
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O O
CO2Et
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  (83%)
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      (81%)
H
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Different Isobenzofuran Structures 
 
We also used the same cycloadolization process to synthesize 2,4-dichlorobenzaldehyde 
and 2,3-dichlorobenzaldehye analogs (scheme 6). The results of these compounds’ cytotoxicity 
are not yet known, but they will offer valuable information regarding the significance of the 
halogen used and its ortho, meta or para placement. With each of these analogs, more analogs 
can be made by changing the ester into a variety of different functional groups. Thus, a library of 
compounds with varying characteristics will exist and which characteristics affect the 
compounds’ cytotoxicity can be determined. 
    
 Scheme 6 
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Scheme 6 continued 
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Changing the Ester Functional Group 
 
 After the cycloadolization the functional groups can be changed. To change the ester 
functional group, a transesterfication reaction was previously attempted. Although the reaction 
worked, the yields were not as good as desired. To obtain a usable yield, large amounts of the 
alcohol had to be used. This was not ideal because a reaction that would require a precious 
alcohol would become very expensive and simply ridding of the alcohol from the product can 
become very tedious.    
This summer we worked on changing the ester by first making a carboxylic acid 
intermediate, then changing the acid into the desired functional group (scheme 7). We studied 
this hydrolysis mechanism on the 2-bromobenzaldehyde analog. The ester was hydrolyzed by 
using an aqueous alcohol and base. Ideally, the hydroxy could then be easily replaced with a 
chosen nucleophile. Thus, several different analogues could be made and assayed. We tried to 
make the carboxylic acid several times using different solvents and bases (table 1). It proved 
difficult to obtain a clean acid, but we succeeded with a few samples. Through the many 
reactions we ran, we found that the reaction goes faster using MeOH as the solvent.5 Also, when 
the base used was too strong or in too great a quantity, instead of getting the acid as the product, 
diene was formed because the alcohol was deprotonated (scheme 8).  
                
 
                  Scheme 7 
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Scheme 8 
O Ar
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                                                        Table 1 
Solvent Base 
MeOH NaOH 
THF NaOH 
MeOH KOH 
MeOH K2CO3 
MeOH LiOH 
 
 
The Oxidative Rearrangement 
 
 Very little is known about why the isobenzofuran exhibits cytotoxicity, if the reason 
could be discovered it would provide valuable information for further research. In an attempt to 
do this an oxidative rearrangement was performed on the isobenzofuran to yield an enone ester 
(scheme 9). The reaction involved making a chromium ester intermediate that displaced the 
oxygen from the hydroxy group and made the enone ester. This was done by allowing a solution 
of the isobenzofuran in CH2Cl2 to be mixed with a solution of PCC in silica gel and stirred for 
24 h at room temperature. The crude yield of this reaction is about 90%. The enone ester has a 
cytotoxicity of about 70 μmol/ L, which is significantly less effective then the tertiary alcohol 
analog’s 20 μmol/ L. The tentative theory the McIntosh group plans on testing involves the 
isobenzofuran’s natural decomposition into a diene. When allowed to sit, the 2-
bromobenzaldehyde analog decomposes into this diene (scheme 8). In the body this natural 
decomposition may also occur except the β-lactone may be intercepted by a enzyme before the 
diene is formed (scheme 10). This reaction is a possible explanation for the compound’s activity 
in the cellular assay. What makes the isobenzofuran decompose, or how it decomposes in the 
body is not yet known. A possibility is that the alcohol that is removed from the enone ester is 
key to the decomposition process. However, these theories are currently very tentative.      
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            Scheme 9 
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                                         Scheme 10 
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Future Research 
 
 The direction the McIntosh group takes as we continue our research will depend on the 
results of assaying the new compounds that have been made. If they find that the halogens and 
their placement on the benzaldehyde ring have no effect on the activity, they will focus on 
varying a different component on the structure such as continuing to replace the ester or finding 
mechanisms that could be used to replace the alcohol or alkene functional groups.  
Also, determining more about the enone ester’s activity and the mechanism that makes it 
behave so differently than the isobenzofuran alcohol will continue to be explored.    
 
Experimental Procedures 
 
Aldol (scheme 5) 
A solution of n-BuLi (19.4 mL, 49.83 mmol), diisopropylamine (7.0 mL, 49.83 mmol) and THF 
(150 mL) was made at -78ºC. After 30 minutes the (S)-(+) carvone (5.21 mL, 33.22 mmol) was 
added rapidly to the solution and allowed to stir for 30 minutes. Then, bromobenzaldehyde (4.63 
mL, 39.86 mmol) was gradually added over the next 30 minutes. The solution was allowed to stir 
overnight, then was warmed to room temperature and diluted with ether and washed with water. 
The aqueous layer was extracted with ether (3x50 mL) and the combined organic layer was 
washed with brine (50 mL) and dried over MgSO4. The solvent was removed with vacuo and the 
compound purified with flash chromatography over silica gel (10/90, EtOAc, Hexane). 
 
Glycolate (scheme 5) 
DMF (8.23 mL, 106 mmol), ethyl bromoacetate (11.7 mL, 106 mmol), and Ag2O (24.6 g, 106 
mmol) were added to the aldol at room temperature. Then, 2,6-Lutidine (12.4 mL, 106 mmol) 
was gradually added over the next 4 hours. The solution was allowed to stir overnight and was 
then filtered over a short silica gel plug. Then it was washed with water and the aqueous layer 
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extracted with ether (3x50 mL). The combined organic layer was then washed with saturated 
NaHCO3 (50 mL), then brine (50 mL) and dried over MgSO4. The solvent was removed with in 
vacuo to yield a dark brown oil wish was purified through flash chromatography over silica gel 
(10/90, EtOAc/ Hexane).   
 
Cycloaldol (scheme 5) 
KHMDS (16.8 mL, 0.5 M in Toluene, 8.4 mmol) was quickly added to the gycolate in ether at -
78ºC. Then AcOH (0.6 mL, 11.4 mmol) was quickly added to the reaction and allowed to stir for 
15 min. The reaction was warmed to room temperature and diluted with ether then washed with 
water. The aqueous layer was extracted with ether (3x50mL) and the combined organic layer 
washed with brine (30mL) and dried over MgSO4. The solvent was removed by vacuo and the 
crude cycloaldol purified by flash chromatography over silica gel (10/90, EtOAc/ Hexane). 
 
Enone Ester (scheme 9) 
Isobenzofuran (0.10 g, 0.237 mmol) was dissolved in anhydrous CH2Cl2 (2.4 mL) and added to 
a premixed mixture of PCC (0.56 g, 2.44 mmol)/silica gel (0.56 g). The reaction stirred 
overnight, then another half equivalent of PCC (0.28 g) was added to the solution and it stirred 
for another 24 h. The compound was then run over a short silica gel plug with ether. The solvent 
was removed by vacuo then purified through flash chromatography over silica gel (10/90 
EtOAc/Hexane) to yield enone as an off-white solid.   
 
Carboxylic Acid (scheme 7) 
The KOH (27.8 g, 405 mmol), MeOH (5.0 mL) and water (5.0 mL) were added to the ethyl ester 
and allowed to stir overnight at 50ºC. The solution was washed with 0.1 M HCl (20mL) then 
separated with dimethylchloride (3x20mL). The solvent was removed through vacuo and the 
compound purified through flash chromatography over silica gel (10/90 EtOAc/Hexane). 
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Organolithium Chemistry:  Transmetalation, Electrophilic Substitution, and Cross-
Coupling Reactions of Organolithium with Boron Trifluoride 
Carol J. Michael-Trana, University of Arkansas at Monticello 
Monticello, Arkansas 
 
Abstract 
 
 Research has demonstrated that potassium organotrifluoroborates can be formed 
via electrophilic substitution reactions and that they make stable intermediates in cross-
coupling reactions.  However, α-lithiated piperidines have been shown to be excellent 
nucleophiles for transmetalation and electrophilic substitution reactions.  Our efforts to 
synthesize a lithium organotrifluoroborate using an α-lithiated piperidine, as well as 
subsequent cross-coupling reactions utilizing this compound are presented.   
 
Introduction 
 
Much of organic chemistry is directed towards the synthesis of new compounds or the 
development of alternate or improved methods in the known synthetic pathways of compounds.  
The organoboron compounds have a wide-ranging importance in the synthesis of organic 
molecules because they have a unique reactivity and they function as organometallic 
intermediates in the generation of organic compounds1.  For this reason, they are valued as 
starting materials and intermediates.   Unfortunately, many of the organoboron derivatives 
involve cross-coupling reactions that are expensive and somewhat unreliable.  Thus some effort 
has been devoted to the development of potassium organotrifluoroborates for use in these 
reactions 2.   We have now undertaken the synthesis of lithium organotrifluoroborates based on 
transmetalation and electrophilic substitution of α-lithiated piperidines because these compounds 
can be used as selective reagents in the synthesis of biologically active compounds.   
 
In the early 1990’s, Beak and Lee demonstrated the preparation of Boc-protected 
piperidines as the basis for the formation of α-lithiated Boc-piperidines and subsequent 
electrophilic substitution reactions involving carbonyl, TMS-Cl, or Bu3SnCl electrophiles 3 (EQ. 
1).  
 
                        
N M
R
N
R
E
E+
R = Boc     M = Li Electrophile = carbonyl, TMS-Cl, 
                       or Bu3SnCl  
(EQ. 1) 
 
Following this, Gawley and Zhang reported the stereoselective mechanisms of alkylation 
of α-lithiated N-methyl-heterocycles 4.   They prepared 2-lithio-N-methylpiperidines using 
Beak’s method for 2-lithio-N-Boc-stannylpiperidine, followed by DIBAL-H reduction of the 
Boc group to a methyl group; then transmetalating the tin to lithium 5.   Their study of the 
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alkylation of lithiated methylpiperidines revealed that these compounds are able to 
stereoselectively react with many electrophiles such as alkyl halides or carbonyl electrophiles 4.  
(EQ. 2) 
(EQ. 2)              
N M
R
N
R
E
E+
R = Me     M = Li Electrophile = alkyl halide or
                       carbonyl electrophile  
 
Working with pyrrolidines instead of piperidines, Campos, et al, at Merck Research 
Laboratories have recently synthesized 2-arylpyrrolidines (a 5-carbon heterocycle instead of a 6-
carbon ring) via s-BuLi/sparteine-mediated deprotonation of N-Boc-pyrrolidine followed by the 
palladium-catalyzed reaction of the resulting 2-lithio-N-Boc-pyrrolidine with an arylhalide 6.   
Research by R. Karl Dieter at Clemson University has produced similar results using a copper-
halide as the metal intermediate 7 (EQ. 3). 
 
           (EQ.3)       
N
Boc
s-BuLi
(-)-sparteine
ZnCl2 N
Boc
M N
Boc
E
M = Li, ZnX, CuX
Pd-cat
E+
Electrophile = Ar-X  
 
 Along these same lines, the Molander Group at the University of Pennsylvania has done 
extensive research on the development of potassium organotrifluoroborates, for use as 
organoboron intermediates, utilizing similar transmetalation/electrophilic substitution reactions.  
This group has demonstrated that the potassium organotrifluoroborates are effective reagents in 
palladium-catalyzed Suzuki-Miyaura-type cross-coupling reactions 1,2,8 (EQ. 4). 
   
            (EQ. 4)    
O
( )2
BF3K
Br-Ph-CN
PdCl2(dppf) CH2Cl2
Cs2CO3
CNOH
OH
( )2
 
 
The investigation the synthesis of lithium organotrifluoroborates utilizing the previously 
discussed transmetalation and electrophilic substitution reactions of piperidines as well as as the 
subsequent cross-coupling reaction of the BF3 product is now described. 
 
Results and Discussion 
 
 The overall organization of our synthesis was to prepare the N-Boc-piperidine and N-
Boc-2-tributylstannylpiperidine by Beak’s method 3 and the N-methyl-2- tributylstannyl-
piperidine and DIBAL-H reduction using Gawley’s approach 4.  We then planned to produce the 
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lithium organotrifluoroborate and perform the subsequent cross-coupling reaction according to 
the following plan: 
 
             
N Li
BF3OEt2
THF N BF3
Li+ ArBr
Pd (II) N
R
Ar
R R  
 
 Our synthesis of N-methyl-2-(trifluoroborate)piperidine began with the preparation of the 
Boc-protected piperidine which we then reacted with s-BuLi to form the α-lithiated Boc-
piperidine 3.  The lithium of this 2-lithio-N-Boc-heterocycle was replaced with SnBu3 via a 
transmetallation reaction using Bu3SnCl, followed by DIBAL-H reduction (Scheme 1).  The N-
Boc-piperidine compound was confirmed by GC-MS.  The N-Boc-2-tributylstannyl-piperidine 
was purified on a silica gel column and confirmed by 1H NMR.  The DIBAL-H reduction to N-
methyl-2-tributylstannylpiperidine was determined by 1H NMR without the need for further 
purification. 
 
         Scheme 1 
 
        
-78 C
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, Et2O
N
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Et3N
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N
Me
SnBu3
 
         
 
 Transmetalation of the N-methyl-2-tributylstannylpiperidine with butyllithium in THF 
occurred at -78 ˚C in one hour 4.  This organolithium was then reacted with BF3·OEt2 at  
-78 ˚C for one hour (Scheme 2).  And here is where we ran into some difficulty with solubility.  
It was not possible to analyze the presumed lithium organotrifluoroborate product for yield or to 
characterize it due to the solubility issues.   We noted that Molander and Biolatto also reported 
solubility problems with the synthesis of organotrifluoroborates 9.   
   
 
Scheme 2 
 
                       
N
Me
SnBu3
n-BuLi
THF
N Li
Me
BF3.OEt2
N
Me
BF3-78  C
Li+
 
 
 
 This synthesis was attempted several times with identical results.  We then tried N-Boc-2-
tributylstannylpiperidine (instead of N-methyl-2- tributylstannylpiperidine) to produce N-Boc-2-
trifluoroborate, as well as several variations of the order of the reactants as well as the 
temperature.  The solubility issues continued to plague every reaction.  In addition, potassium 
tert-butoxide was also added either before or after the addition of BF3·OEt2.  Each of these two 
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reactions resulted in an insoluble powder.  The powder was examined under a dissecting 
microscope and displayed a crystalline structure typical of a salt, but the crystals were not suited 
for study by x-ray crystallography.   In spite of the solubility difficulties, we attempted several 
types of NMR studies, but readings were inconclusive.  Finally a “No-D Boron-11 NMR” 
approach was tried with results which appeared to confirm the presence of BF3 (Figure 1). 
 
 
            
 Figure 1:  “No-D Boron-11 NMR” study. 
 
 
 It was then decided to continue on to the cross-coupling reaction.  If the lithium 
organotrifluoroborate had actually been produced, as we believed it had, then the “one-pot”, 
palladium-(II)-catalyzed cross-coupling reaction should take place as predicted (Scheme 3).  A 
reaction did occur and was characterized by GC-MS (Figures 3a-f).  Two m/z 176 peaks 
(C12H17N) were noted.  The first (Rt 6.15 min) is presumed to be N-methyl-2-phenylpiperidine; 
the second (Rt 6.35 min) was shown by independent synthesis to be N-benzylpiperidine (Figures 
2a-b, 3a).  Also, a demethylated product, a hexylated product, and an unknown were observed 
(Figures 2c-f, 3a).   
Scheme 3 
 
 
N
Me
SnBu3 BF3.OEt2
-78  C
THF
n-BuLi
N
Me
BF3
Li+
N
Me
Cs2CO3
BrPh
PdCl2(dppf)·CH2Cl2
THF, reflux overnight  
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N
H Ph
N
C6H13
CH3
N Ph
CH3
N
Ph
   (Presumed) 
m/z 176  Rt 6.15
Proven independently
m/z 176  Rt 6.35 m/z 162  Rt 6.48
(Presumed)
m/z 184  Rt 6.26
    C15H25N
m/z 220  Rt 6.89
      Bu4Sn
m/z 291  Rt 7.43
                     
              2a                            2b                        2c                          2d                        2e-f 
    Figure 2a-f:  Possible compounds in palladium-catalyzed cross-coupling reaction mixture. 
 
 
 
 
 
           
            Figure 3a:  GC-MS study of Pd(II)-catalyzed reaction mixture. 
 
Target 
176-2 
176-1 
184 
162 
220 291 
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     Figure 3b:  GC-MS study of Pd(II)-catalyzed reaction mixture. 
 
   
                                            
 
       Figure 3c:  GC-MS study of Pd(II)-catalyzed reaction mixture. 
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         Figure 3d:  GC-MS study of Pd(II)-catalyzed reaction mixture. 
             
 
 
 
   
 
          Figure 3e:  GC-MS study of Pd(II)-catalyzed reaction mixture. 
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        Figure 3f:  GC-MS study of Pd(II)-catalyzed reaction mixture.     
 
 
 As noted, the thus-far unresolvable issues with solubility prevented analysis and 
characterization of the lithium organotrifluoroborate product.  We do believe, however, that this 
compound has been synthesized due to the presence of Bu4Sn on the 1H NMR, the appearance of 
the “No-D Boron-11 NMR”, as well as the results on GC-MS of the cross-coupling reaction that 
followed.   
 
  The GC-MS study of the palladium-catalyzed cross-coupling reaction of the presumed 
lithium organotrifluoroborate reagent to the N-methyl-2-phenylpiperidine product showed that a 
reaction did occur.  As discussed previously, the presence of a second 176 peak was noted and 
has been determined to be N-methylbenzylpiperidine.  Purification of the target product, as well 
as yield data and combustion analysis, has not been accomplished to date.   
 
 
Conclusions 
 
 The investigation of the synthesis of lithium organotrifluoroborates is still in the 
exploratory phase.  The presence of SnBu4 on the 1H NMR study is promising.  The 
confirmation on GC-MS of the targeted arylheterocycle from the cross-coupling reaction is also 
encouraging. Future considerations should include the resolution of the solubility issues that 
have made the analysis and characterization of these products problematic and a better 
understanding of the mechanisms involved in these reactions as well as the cross-coupling 
reaction with the lithium organotrifluoroborate reagent. 
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